Agritech Worldwide (FBER) Inactive 10-K14 Apr 142013 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2013	Apr. 15, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'Z TRIM HOLDINGS, INC	'	'
Entity Central Index Key	'0001052257	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$47,785,197
Entity Common Stock, Shares Outstanding	'	39,734,854	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'

BALANCE_SHEET

BALANCE SHEET (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash and cash equivalents	$443,472	$644,804
Accounts receivable	380,238	299,256
Inventory	544,535	469,302
Prepaid expenses and other assets	136,887	136,827
Total current assets	1,505,132	1,550,189
Long Term Assets	'	'
Note receivable	550,650	523,150
Other assets	11,892	11,892
Property and equipment, net	1,800,306	2,445,965
Total long term assets	2,362,848	2,981,007
TOTAL ASSETS	3,867,980	4,531,196
Current Liabilities	'	'
Accounts payable	374,566	328,887
Accrued expenses and other	194,144	173,534
Accrued liquidated damages	36,178	36,178
Derivative liabilities	95,049	8,025,381
Total Current Liabilities	699,937	8,563,980
Total Liabilities	699,937	8,563,980
Stockholders' Equity (Deficit)	'	'
Common stock, $0.00005 par value; authorized 200,000,000 shares; issued and outstanding 39,449,138 and 25,032,444 shares, December 31, 2013 and 2012, respectively	1,973	1,252
Common stock payable	0	2,358,107
Additional paid-in capital	130,039,561	104,891,849
Accumulated deficit	-126,873,491	-113,441,230
Total Stockholders' Equity (Deficit)	3,168,043	-4,032,784
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	3,867,980	4,531,196
Series II [Member]	'	'
Stockholders' Equity (Deficit)	'	'
Convertible Preferred Stock Series II, $0.01 par value; authorized 1,000,000 shares, issued and outstanding 0 and 665,339 shares, December 31, 2013 and 2012, respectively	$0	$2,157,238

BALANCE_SHEET_Parenthetical

BALANCE SHEET (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Stockholders' Equity (Deficit)	'	'
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	39,449,138	25,032,444
Common stock, shares outstanding (in shares)	39,449,138	25,032,444
Series II [Member]	'	'
Stockholders' Equity (Deficit)	'	'
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	665,339
Preferred stock, shares outstanding (in shares)	0	665,339

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Dec. 31, 2013	Dec. 31, 2012
REVENUES:	'	'
Products	$1,429,419	$1,274,649
Total revenues	1,429,419	1,274,649
COST OF REVENUES:	'	'
Products	2,857,947	2,609,892
Inventory valuation reserve	742,168	0
Total cost of revenues	3,600,115	2,609,892
GROSS MARGIN	-2,170,696	-1,335,243
OPERATING EXPENSES:	'	'
Selling, general and administrative	6,480,031	4,707,678
Total operating expenses	6,480,031	4,707,678
OPERATING LOSS	-8,650,727	-6,042,921
OTHER INCOME (EXPENSES):	'	'
Rental and other income	0	4,225
Interest income	27,558	23,411
Interest expense - other	-2,037	-107
Interest expense - note payable	0	-97,363
Change in fair value - derivative	966,736	-1,514,156
Gain (loss) on asset disposals, net	-1,334	49,101
Loss on equity modification	-5,780,457	0
Loss on preferred stock conversion	0	-728
Settlement gain (loss)	8,000	-2,005,218
Total other income (expenses)	-4,781,534	-3,540,835
NET LOSS	-13,432,261	-9,583,756
Less Preferred Dividends	56,144	584,135
Accretion of Discount on Preferred Stock	0	3,684,317
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	($13,488,405)	($13,852,208)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share)	($0.41)	($0.76)
Weighted Average Number of Shares Basic and Diluted (in shares)	32,862,216	18,216,576

STATEMENT_OF_STOCKHOLDERS_EQUI

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Common Stock [Member]	Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]	Common Stock Payable [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2011	$707	$0	$91,262,428	$0	($103,857,474)	($12,594,339)
Balance (in shares) at Dec. 31, 2011	14,139,621	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Stock issued for directors fees	12	0	159,988	0	0	160,000
Stock issued for directors fees (in shares)	238,800	'	'	'	'	'
Stock and warrants issued for services	8	0	149,992	0	0	150,000
Stock and warrants issued for services (in shares)	150,000	'	'	'	'	'
Stock issued for cash, net of offering costs	116	0	3,789,812	0	0	3,789,928
Stock issued for cash, net of offering costs (in shares)	2,346,228	'	'	'	'	'
Stock returned as a result of services	-2	0	2	0	0	0
Stock returned as a result of services (in shares)	-42,000	'	'	'	'	'
Stock issued for conversion of convertible notes	94	0	1,870,940	0	0	1,871,034
Stock issued for conversion of convertible notes (in shares)	1,871,035	'	'	'	'	'
Exercised warrants for cash	25	0	304,200	0	0	304,225
Exercised warrants for cash (in shares)	490,424	'	'	'	'	'
Exercised cashless warrants	10	0	-10	0	0	0
Exercised cashless warrants (in shares)	198,663	'	'	'	'	'
Exercised stock options for cash	1	0	9,525	0	0	9,526
Exercised stock options for cash (in shares)	14,600	'	'	'	'	'
Exercised cashless stock options	7	0	-7	0	0	0
Exercised cashless stock options (in shares)	131,161	'	'	'	'	131,161
Stock issued for conversion of convertible redeemable preferred stock	274	0	5,493,640	0	0	5,493,914
Stock issued for conversion of convertible redeemable preferred stock (in shares)	5,493,912	'	'	'	'	'
Stock based compensation - stock options	0	0	1,547,826	0	0	1,547,826
Discount on notes payable issued	0	0	40,508	0	0	40,508
Derivative settlement	0	0	4,520,207	0	0	4,520,207
Dividends declared	0	0	-584,135	0	0	-584,135
Amortization of discount	0	0	-3,684,317	0	0	-3,684,317
Stock issued for services - vested	0	0	11,250	0	0	11,250
Stock to be issued for settlement loss	0	0	0	1,881,250	0	1,881,250
Reclass convertible, redeemable preferred stock to convertible preferred stock, net of discount	0	2,157,238	0	476,857	0	2,634,095
Reclass convertible, redeemable preferred stock to convertible preferred stock, net of discount (in shares)	0	665,339	'	'	'	'
Net loss	0	0	0	0	-9,583,756	-9,583,756
Balance at Dec. 31, 2012	1,252	2,157,238	104,891,849	2,358,107	-113,441,230	-4,032,784
Balance (in shares) at Dec. 31, 2012	25,032,444	665,339	'	'	'	25,032,444
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Stock issued for directors fees	5	0	199,997	0	0	200,002
Stock issued for directors fees (in shares)	114,944	'	'	'	'	'
Stock and warrants issued for services	39	0	630,894	0	0	630,933
Stock and warrants issued for services (in shares)	770,000	'	'	'	'	'
Stock issued for cash, net of offering costs	136	0	2,172,029	0	0	2,172,165
Stock issued for cash, net of offering costs (in shares)	2,711,238	'	'	'	'	'
Exercised warrants for cash	114	0	2,489,732	0	0	2,489,846
Exercised warrants for cash (in shares)	2,287,730	'	'	'	'	'
Exercised cashless warrants	180	0	-180	0	0	0
Exercised cashless warrants (in shares)	3,606,157	'	'	'	'	'
Exercised stock options for cash	5	0	77,729	0	0	77,734
Exercised stock options for cash (in shares)	91,400	'	'	'	'	'
Exercised cashless stock options	5	0	-5	0	0	0
Exercised cashless stock options (in shares)	100,528	'	'	'	'	100,528
Stock issued for conversion of convertible redeemable preferred stock	193	-2,157,238	2,690,046	-533,001	0	0
Stock issued for conversion of convertible redeemable preferred stock (in shares)	3,859,697	-665,339	'	'	'	'
Stock based compensation - stock options	0	0	2,318,355	0	0	2,318,355
Equity modification on warrants exercised	'	'	5,780,457	'	'	5,780,457
Derivative settlement	0	0	6,963,596	0	0	6,963,596
Dividends declared	0	0	-56,144	56,144	0	0
Amortization of discount	'	'	'	'	'	0
Stock issued for settlement loss	44	0	1,881,206	-1,881,250	0	0
Stock issued for settlement loss (in shares)	875,000	'	'	'	'	'
Net loss	0	0	0	0	-13,432,261	-13,432,261
Balance at Dec. 31, 2013	$1,973	$0	$130,039,561	$0	($126,873,491)	$3,168,043
Balance (in shares) at Dec. 31, 2013	39,449,138	0	'	'	'	39,449,138

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
STATEMENTS OF CASH FLOWS (USD $)	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net loss	($13,432,261)	($9,583,756)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:	'	'
Stock based compensation - stock options vested	2,318,355	1,547,826
Common shares issued for director fees	200,002	160,000
Shares & warrants issued for services	630,933	161,250
Loss on equity modification	5,780,457	0
Amortization of debt discount	0	78,819
Depreciation	643,575	682,134
(Gain) loss on disposal of equipment	1,334	-49,101
Inventory valuation reserve	742,168	0
Change in derivative liability, net of bifurcation	-966,736	1,514,156
Loss on preferred stock conversion	0	728
Settlement loss payable in common stock	0	1,881,250
Adjustment to settlement loss accrual	-8,000	110,000
Changes in operating assets and liabilities:	'	'
Accounts receivable	-80,982	16,021
Inventory	-817,401	-212,460
Prepaid expenses and other assets	-60	-28,244
Note receivable	-27,500	-437,935
Accounts payable and accrued expenses	74,289	77,364
CASH USED IN OPERATING ACTIVITIES	-4,941,827	-4,081,948
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Proceeds from sale of fixed assets	750	110,000
CASH PROVIDED BY INVESTING ACTIVITIES	750	110,000
CASH FLOWS FROM FINANCING ACTIVITES	'	'
Proceeds from sale of common stock, net	2,172,165	3,789,928
Proceeds from exercise of stock options	77,734	9,526
Proceeds from exercise of warrants	2,489,846	304,225
Borrowing on debt	0	200,000
CASH PROVIDED BY FINANCING ACTIVITIES	4,739,745	4,303,679
NET (DECREASE) INCREASE IN CASH	-201,332	331,731
CASH AT BEGINNING OF PERIOD	644,804	313,073
CASH AT THE PERIOD ENDED DECEMBER 31	443,472	644,804
Supplemental Disclosures of Cash Flow Information:	'	'
Cashless exercise of warrants	180	10
Cashless exercise of options	5	7
Shares issued for stock payable related to settlement loss	1,881,250	0
Note payable conversion	0	1,871,034
Preferred stock conversion	2,690,056	5,493,914
Amortization on preferred stock discount	0	3,684,317
Settlement of derivative liability due to conversion of note payable	0	48,619
Change in derivative liability due to exercise of warrants	4,201,908	2,864,275
Change in derivative liability due to conversion of preferred stock	2,761,688	1,607,313
Dividends payable declared	56,144	584,135
Unvested shares returned by vendor	0	2
Discount on convertible debt due to attached warrants	0	40,508
Dividends payable reclassed to equity with preferred stock modification	0	476,857
Preferred stock series II reclassed to equity with modification	$0	$2,157,238

NATURE_OF_BUSINESS

NATURE OF BUSINESS	12 Months Ended
NATURE OF BUSINESS	Dec. 31, 2013
NATURE OF BUSINESS [Abstract]	'
NATURE OF BUSINESS	'
	NOTE 1 – NATURE OF BUSINESS

	Z Trim Holdings, Inc. (the “Company”) is an agricultural ingredient technology company that owns existing, and has developed new, products and processes to make use of biomass for uses in the food and industrial markets. The Company’s food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems. The Company’s technology provides value-added ingredients across virtually all food industry categories. The Company’s all-natural products, among other things, help to reduce fat and calories, add fiber, provide shelf-stability, prevent oil migration, and add binding capacity – all without degrading the taste and texture of the final food products. Perhaps most significantly, Z Trim’s products can help extend finished products, and thereby increase its customers’ gross margins. The Company’s industrial division, opened in 2012, plans to sell eco-friendly ingredients to oil drilling, hydraulic fracturing, petroleum coke, steel/aluminum, paper and other industries. The Company’s industrial ingredients are highly functional in applications for adhesives, binders, viscofiers and emulsifiers.

GOING_CONCERN

GOING CONCERN	12 Months Ended
GOING CONCERN	Dec. 31, 2013
GOING CONCERN [Abstract]	'
GOING CONCERN	'
	NOTE 2 –GOING CONCERN

	The financial statements have been prepared assuming that the Company will continue as a going concern. As of April 11, 2014, the date that the independent registered public accountant issued its report on the audited financial statements as of and for the year ended December 31, 2013, the Company did not have enough cash on hand to meet its current liabilities or to fund on-going operations beyond one year. The Company had reoccurring losses as of December 31, 2013. As a result, the independent registered public accountant’s audit report included an explanatory paragraph in respect of our ability to continue as a going concern. The Company intends to secure additional funding through debt or equity financing arrangements, increased sales generated by its operations and reduced expenses.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Use of Estimates

	The preparation of the accompanying financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

	Revenue Recognition

	The Company generally recognizes product revenue when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable. In instances where the final acceptance of the product is specified by the customer, revenue is deferred until all acceptance criteria have been met. No provisions were established for estimated product returns and allowances based on the Company’s historical experience.

	Allowance for Doubtful Accounts


	Management of the Company makes judgments as to its ability to collect outstanding receivables and provide allowances for the portion of receivables when collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding invoices. For those invoices not specifically reviewed, provisions are provided at differing rates, based upon the age of the receivable. In determining these percentages, management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables, additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31, 2013 and 2012, the allowance for doubtful accounts was $0.

	Cash and cash equivalents

	For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. There were no cash equivalents as of December 31, 2013 and 2012.

	Inventory

	Inventory is stated at the lower of cost or market, using the first-in, first-out method. The Company follows standard costing methods for manufactured products.

	Property and Equipment

	Property and equipment are stated at cost less accumulated depreciation and amortization. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Estimated useful lives of five to ten years are used for machinery and equipment, office equipment and furniture, and automobile. Estimated useful lives of up to five years are used for computer equipment and related software. Depreciation and amortization of leasehold improvements are computed using the term of the lease.

	Intangible Assets

	Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally from fifteen to twenty years.

	Impairment of Long-Lived Assets

	Long-lived assets and certain identifiable intangible assets to be held and used are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of such assets may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. Measurement of an impairment loss for long-lived assets and certain identifiable intangible assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets and certain identifiable intangible assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

	Income Taxes

	The amount of current and deferred taxes payable or refundable is recognized as of the date of the financial statements, utilizing currently enacted tax laws and rates. Deferred tax expenses or benefits are recognized in the financial statements for the changes in deferred tax liabilities or assets between years.

	Accounting for Derivative Instruments

	All derivatives have been recorded on the balance sheet at fair value based on the lattice model calculation. These derivatives, including embedded derivatives in the Company’s warrants, convertible preferred stock, and its Convertible 8% Senior Secured Notes issued in 2008, 2009, and 2010, which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes, are separately valued and accounted for on the Company’s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.

	Lattice Valuation Model

	The Company valued the warrants and conversion features in their convertible notes and preferred stock using a lattice valuation model, with the assistance of a valuation consultant. The lattice model values these instruments based on a probability weighted discounted cash flow model. The Company uses the model to develop a set of potential scenarios. Probabilities of each scenario occurring during the remaining term of the instruments are determined based on management's projections and the expert’s calculations. These probabilities are used to create a cash flow projection over the term of the instruments and determine the probability that the projected cash flow will be achieved. A discounted weighted average cash flow for each scenario is then calculated and compared to the discounted cash flow of the instruments without the compound embedded derivative in order to determine a value for the compound embedded derivative.

	Fair Value of Financial Instruments

	The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, inventory, accounts payable and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.

	The Company utilizes various types of financing to fund its business needs, including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and, if so, whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31, 2013 and 2012, the Company had warrants to purchase common stock, the fair values of which are classified as a liability.
	Inputs used in the valuation to derive fair value are classified based on a fair value hierarchy which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

	- Level one — Quoted market prices in active markets for identical assets or liabilities;
	- Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
	- Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

	Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31, 2013 and 2012 was $95,049 and $8,025,381, respectively. The gain on derivative liability for the twelve months ended December 31, 2013 was $966,736 compared to a loss on derivative liability of $1,514,156 for the twelve months ended December 31, 2012. Below is a hierarchy table of the components of the derivative liability:

			Carrying		Fair Value Measurements Using
			Value		Level 1		Level 2		Level 3		Total

Derivative Liabilities
12/31/11		$11,031,432		$-		$-		$11,031,432		$11,031,432

Change in derivative liabilities due to
settlements		(4,520,207)		-		-		(4,520,207)		(4,520,207)
Change in derivative liabilities valuation		1,514,156		-		-		1,514,156		1,514,156
		(3,006,051)		-		-		(3,006,051)		(3,006,051)

Derivative Liabilities
12/31/12		$8,025,381		$-		$-		$8,025,381		$8,025,381

Change in derivative liabilities due to
settlements		(6,963,596)		-		-		(6,963,596)		(6,963,596)
Change in derivative liabilities valuation		(966,736)		-		-		(966,736)		(966,736)
		(7,930,332)		-		-		(7,930,332)		(7,930,332)

Derivative Liabilities
12/31/13		$95,049		$-		$-		$95,049		$95,049

Accounting for Convertible, Redeemable Preferred Stock

The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company’s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense, and discounts on instruments classified within permanent or temporary equity are amortized to retained earnings or additional paid in capital when there is an accumulated deficit. Amortization of discounts on preferred shares classified within equity or temporary equity is deducted from net income to common shareholders on the income statement.

Advertising Costs

The Company expenses all advertising costs as incurred. The amount for the year ended December 31, 2013 and 2012 was $250 and $18,425 respectively.

Income (Loss) Per Common Share

Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common stock outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding and, when diluted, potential shares from options and warrants to purchase common stock using the treasury stock method. Diluted net loss per common share does not differ from basic net loss per common share since potential shares of common stock are anti-dilutive for all periods presented.

Cashless Exercise of Warrants/Options

The Company has issued warrants and options to purchase common stock where the holder is entitled to exercise via a cashless exercise. The Company accounts for the issuance of common stock on the cashless exercise of warrants and options on a net basis.

Stock-Based Compensation

The Company estimates the fair value of share-based payment awards made to employees and directors, including stock options, restricted stock and employee stock purchases related to employee stock purchase plans, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods. We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2,318,355 and $1,547,826 for the years ended December 31, 2013 and 2012, respectively.

Note Recievable

The Company has entered into a custom processing agreement with a vendor in order to provide the Company with a partner for future manufacturing initiatives. The Company has agreed to make available a $500,000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75,000 during any thirty day period. The Company will be re-paid for these advances with future discounts on products manufactured by the vendor.

The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account, and will be realized with future discounts as well.

On March 28, 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest. Commencing on April 1, 2014, Aveka Nutra Processing will begin paying the Company $5,000 per month to be applied to advances and accrued interest.

New Accounting Pronouncements

Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income

In February 2013, the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented, or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides, subject to certain conditions, the option to perform a qualitative, rather than quantitative, assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company’s financial position, results of operations or cash flows.

Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists

In July 2013, the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. The update will be effective in the first quarter of 2014, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

Testing Indefinite-Lived Intangible Assets for Impairment

In July 2012, the FASB issued an accounting standards update which provides, subject to certain conditions, the option to perform a qualitative, rather than quantitative, assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update may, under certain circumstances, reduce the complexity and costs of testing indefinite-lived intangible assets for impairment, but did not have a material impact on the Company’s financial position, results of operations or cash flows.

INVENTORY

INVENTORY	12 Months Ended
INVENTORY	Dec. 31, 2013
INVENTORY [Abstract]	'
INVENTORY	'
	NOTE 4 – INVENTORY

	At December 31, inventory consists of the following:

		12/31/13	12/31/12
	Raw materials	$27,575	$42,831
	Packaging	8,178	1,873
	Work-in-process	33,527	64,170
	Finished goods	475,255	360,428

		$544,535	$469,302

	At December 31 the Company recognized an inventory valuation reserve of $742,168 as a result of slow moving inventory within the Industrial Products Division.

PROPERTY_AND_EQUIPMENT_NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
PROPERTY AND EQUIPMENT, NET	Dec. 31, 2013
PROPERTY AND EQUIPMENT, NET [Abstract]	'
PROPERTY AND EQUIPMENT, NET	'
	NOTE 5 – PROPERTY AND EQUIPMENT, NET

	At December 31, property and equipment, net consists of the following:

		12/31/13	12/31/12
	Production, engineering and other equipment	$6,422,110	$6,426,432
	Leasehold improvements	2,904,188	2,904,188
	Office equipment and furniture	603,182	603,182
	Computer equipment and related software	140,238	140,238
		$10,069,718	$10,074,040
	Accumulated depreciation	($8,269,412)	($7,628,075)
	Property and equipment, net	$1,800,306	$2,445,965

	Depreciation expense was $643,575 and $682,134 for the years ended December 31, 2013 and 2012, respectively. During the year ended December 31, 2013, the Company sold a fixed asset with a net book value of $2,084 in exchange for cash of $750 and recorded a loss on the sale of $1,334. For the twelve months ended December 31, 2012, the Company sold equipment with a net book value of $60,899 for a total of $110,000 and recorded a gain on the sale of $49,101.

NOTE_RECEIVABLE

NOTE RECEIVABLE	12 Months Ended
NOTE RECEIVABLE	Dec. 31, 2013
NOTE RECEIVABLE [Abstract]	'
NOTE RECEIVABLE	'
	NOTE 6 – NOTE RECEIVABLE

	On October 17, 2011, Z Trim Holdings, Inc. (the “Company”) entered into a Custom Processing Agreement (the “Agreement”) with AVEKA Nutra Processing, LLC (“ANP”), part of the Aveka Group, in order to provide the Company with a partner for future manufacturing initiatives.

	The Agreement provides that ANP will perform certain services related to the Company’s dietary fiber product, including manufacturing, processing, packaging and storage/warehousing for an initial term of three years. The Agreement automatically renews at the end of the initial term for an additional two year term unless either party provides written notice to the other within the specified time frame. Production began during the third quarter of 2012. The Agreement provides for minimum production volumes of 40,000 lbs per month and average volumes of 100,000 lbs. per month with the ability to increase future production volume to potentially as much as 1,000,000 lbs. per month.

	In addition, the Company has agreed to make available to ANP a $500,000 line of credit (which includes $10,000 that the Company loaned ANP to assist it with the purchase of its Waukon, Iowa facility) at an interest rate of 5.5%. The line of credit is only permitted to be used by ANP for operating costs which excludes capital expenditures of equipment in excess of $5,000. ANP may not draw down on the line of credit more than $75,000 in any given thirty day period. The loan is to be paid back to the Company in the form of discounts on production pricing commencing either two years after the first draw by ANP on the line of credit (other than the $10,000 the Company loaned ANP to assist it with the purchase of its Waukon, Iowa facility) or the first month after the Company has ordered 80,000 lbs. of product for three consecutive months, whichever shall occur first. All of ANP’s obligations under the line of credit, as well as the Agreement, are specifically guaranteed by its parent company, Aveka Inc. As of December 31, 2013 we advanced a total of $500,000 and accrued interest on the advance was $50,650. On March 28, 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest. Commencing on April 1, 2014, Aveka Nutra Processing will begin paying the Company $5,000 per month to be applied to advances and accrued interest.

ACCRUED_EXPENSES

ACCRUED EXPENSES	12 Months Ended
ACCRUED EXPENSES	Dec. 31, 2013
ACCRUED EXPENSES [Abstract]	'
ACCRUED EXPENSES	'
	NOTE 7 – ACCRUED EXPENSES

	At December 31, accrued expenses consist of the following:

		12/31/13	12/31/12
	Accrued payroll and taxes	$51,566	$32,021
	Accrued settlements	102,000	110,000
	Accrued expenses and other	40,578	31,513

		$194,144	$173,534

CONVERTIBLE_NOTES_PAYABLE

CONVERTIBLE NOTES PAYABLE	12 Months Ended
CONVERTIBLE NOTES PAYABLE	Dec. 31, 2013
CONVERTIBLE NOTES PAYABLE [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	NOTE 8–CONVERTIBLE NOTES PAYABLE

	2012 CONVERTIBLE NOTES

	During the first quarter of fiscal 2012, we secured financing from three accredited investors (the “Investors”) pursuant to which we sold senior secured convertible promissory notes (each a “Note” and collectively the “Notes”) and warrants and received gross proceeds of $200,000. The Notes have a twenty-four month term and accrue interest at the rate of 8% per annum. The principal balance of the Notes is convertible at the rate of $1.00 per share into an aggregate of 200,000 shares of our common stock, $.00005 par value (the “Common Stock”). The interest is payable either upon maturity of the Notes or quarterly at the Investors’ option in shares of our Common Stock. Any amount of principal or interest which is not paid when due shall bear interest at a rate of interest equal to the eighteen percent (18%) per annum. Attached to the Notes are warrants that entitle the Investor to purchase a specified number of shares of common stock of the Company at a price of $1.50 per share within five years. The warrants value is discounted against the Notes and is being amortized as interest expense using the effective interest method over the term of the Notes. The valuation of the related discount for the warrants was calculated using the Black Scholes model and was equal to $40,508. The key inputs to the model were the number of warrants of 100,000, share prices on the grant dates of $0.59 and $0.70, exercise price of $1.50, terms of 5 years, volatilities of 98.16% and 103.66%, and discount rates of 0.91% and 0.88%. During 2012, the Company recorded amortization of the debt discount in the amount of $40,608.

	On November 5, 2012, the $200,000 principal balance together with accrued and unpaid interest was converted into common stock. As of December 31, 2012, the Company did not have any convertible notes payable outstanding.

	AMORTIZATION ON CONVERTIBLE NOTES

	For the twelve months ended December 31, 2012, the Company recognized debt discount amortization in the amount of $78,819.

PREFERRED_STOCK

PREFERRED STOCK	12 Months Ended
PREFERRED STOCK	Dec. 31, 2013
PREFERRED STOCK [Abstract]	'
PREFERRED STOCK	'
	NOTE 9 - PREFERRED STOCK

	During 2012, the Company entered into an agreement with its largest stockholder, Brightline Ventures I, LLC (“Brightline Ventures I”), pursuant to which Brightline Ventures I agreed to convert $3,326,697 (exclusive of dividends) worth of Series II Preferred Stock into 3,326,697 shares of the Company’s common stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group LLC. In consideration for the foregoing conversion of Series II Preferred Stock by Brightline Ventures I on or before their respective maturity dates, the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of 11,582,983 shares of common stock with an exercise price of $1.50 per share, which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company’s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of 2,859,375 shares of common stock with an exercise price of $1.50 per share, which equaled one half of the outstanding and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company at that time (see Note 12 for a discussion of matters related to these warrants that occurring during 2013). As a result of this modification, the Series II Convertible, Redeemable Preferred Stock was reclassified on the balance sheet as permanent Stockholders’ Equity and identified as Series II Convertible Preferred Stock at December 31, 2012. The value reclassified to permanent equity was equal to the carrying value of the shares on the date the agreement was modified. This value was $2,157,238 based on a gross value of $3,326,697 and a remaining discount of $1,169,459. Furthermore, the accrued dividends relating to the Series II Convertible Preferred Stock were also reclassified to Stockholders’ Equity as of December 31, 2012. These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.

	On March 18, 2013, Brightline Ventures I converted the Series II Convertible Preferred Stock of $3,326,697 together with $533,000 of accrued dividends thereon into 3,859,697 shares of the Company’s Common Stock. As of March 31, 2013 there was no Series II Convertible Preferred Stock outstanding. The value of the Series II Preferred Stock and dividends converted was equal to the total value recorded to common stock and additional paid in capital with no gain or loss recorded as the conversion was consistent with the original agreement. As a result of the preferred stock conversion, $2,690,239 was recorded to common stock and additional paid-in capital. Accrued dividends were $476,857 as of December 31, 2012.

	As of December 31, 2013, no shares of Series II Preferred Stock remained outstanding.
	Preferred Stock converted into Common Stock in 2012
	On August 15, 2012, Brightline Ventures I converted $907,120 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 907,120 shares of the Company’s Common Stock. In conjunction with this conversion, Morris Garfinkle, a Director of the Company, also converted $34,800 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 34,800 shares of the Company’s Common Stock.

	On September 7, 2012, Brightline Ventures I converted $727,280 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 727,280 shares of the Company’s Common Stock.

	On December 7, 2012, Brightline Ventures I converted $2,559,752 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 2,559,752 shares of the Company’s Common Stock. Again on December 29, 2012, Brightline Ventures I converted $905,348 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 905,348 shares of the Company’s Common Stock.

	On December 11, 2012, the Company’s external Directors, Mark Hershhorn, Morris Garfinkle, Brian Israel and Edward Smith each agreed to convert $17,403 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 17,403 shares of the Company’s Common Stock prior to its maturity. The aggregate conversion by the directors was $69,612. As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31, 2012.

	On December 15, 2012, an Investor converted $290,000 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 290,000 shares of the Company’s Common Stock.

	On August 13, 2012, the Company entered into an agreement with Brightline Ventures I pursuant to which Brightline agreed to convert $7,721,988 (exclusive of dividends) worth of Series I and II Preferred Stock into 7,721,988 shares of the Company’s Common Stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group, LLC. In consideration for the foregoing conversion of Preferred Stock by Brightline Ventures I on or before their respective maturity dates, the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of 11,582,983 shares of Common Stock with an exercise price of $1.50 per share, which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company’s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of 2,859,375 shares of Common Stock with an exercise price of $1.50 per share, which equals one half of the outstanding and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company. Prior to December 31, 2012, all Series I Preferred shares held by Brightline Ventures I were converted to common shares consistent with the amendment. The remaining Series II Preferred shares held of 665,339 shares and $3,326,697 was reclassified to permanent equity based on the removal of the redemption feature associated with the preferred stock. The value reclassified was equal to the carrying value of the shares on the date the agreement was modified. This value was $2,157,238 based on a gross value of $3,326,697 and a remaining discount of $1,169,459. Furthermore, the accrued dividends relating to the Series II Convertible Preferred Stock have also been reclassified to Stockholders’ Equity. These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.

	At December 31, 2012, the Company has no outstanding Series I Convertible, Redeemable Preferred Stock. All of the shares of Series II Convertible Preferred Stock outstanding as of December 31, 2012 were owned by related parties.

LIQUIDATED_DAMAGES

LIQUIDATED DAMAGES	12 Months Ended
LIQUIDATED DAMAGES	Dec. 31, 2013
LIQUIDATED DAMAGES [Abstract]	'
LIQUIDATED DAMAGES	'
	NOTE 10 - LIQUIDATED DAMAGES

	In connection with certain private placements of the Company’s securities (the “Registrable Securities”) effected in 2008 the Company entered into registration rights agreements (the “RRA”) that required the Company to file a registration statement covering the Registrable Securities with the Securities and Exchange Commission no later than thirty days after the final closing as contemplated in the Private Placement Memorandum for the 2008 offering (the “Filing Deadline”). The Company filed a registration statement on December 14, 2009. However, the statement had not been declared effective as the Company was not Form S-3 eligible. A Form S-1 registration statement was filed on June 2, 2011, and went effective on June 3, 2011. Under the terms of the registration rights agreement, as partial compensation, the Company would be required to make pro rata payments to each Investor in an amount equal to 1.5% of the aggregate amount invested by such Investor for each 30-day period or pro rata for any portion thereof following the Filing Deadline for which no registration statement was filed. We obtained a release and waiver of the amounts due from 74 of the 2008 investors. As of December 31, 2013, there are 3 investors who have yet to sign the release and waiver. Under the terms of the RRA, as of that date we potentially owe, and recognized as liquidated damages, the amount of $36,178. During 2011, two investors did sign a release and waiver of any such claims, and therefore we recognized a gain of $74,850 related to the reduction of these potential claims.

DERIVATIVE_LIABILITIES

DERIVATIVE LIABILITIES	12 Months Ended
	Dec. 31, 2013
DERIVATIVE LIABILITIES [Abstract]	'
DERIVATIVE LIABILITIES	'
	NOTE 11 –DERIVATIVE LIABILITIES

	Certain of the Company’s warrants (as well as its formerly outstanding preferred stock and Convertible 8% Senior Secured Notes issued in 2008 and 2010) have reset provisions to the exercise price if the Company issues equity or other derivatives at a price less than the exercise price set forth in such warrants. This ratchet provision results in a derivative liability in our financial statements.

	Our derivative liabilities decreased to $95,049 at December 31, 2013 from $8,025,381 at December 31, 2012. The gain recognized during the twelve months ended December 31, 2013 was $966,736 as compared to a loss of $1,514,156 for the twelve months ended December 31, 2012.

	During the twelve months ended December 31, 2013, additional paid in capital increased by $6,963,596 as a result of the March 2013 conversion of the Series II Convertible Preferred Stock by Brightline Ventures I and the exercise of warrants in 2013. The change attributable to the conversion of the preferred stock was $2,761,688 and the change associated with the exercise of warrants was $4,201,908.

	The assumptions used to value the derivative liabilities in the lattice model for the year ended December 31, 2013 included the closing stock price of $0.56 per share, the total market capitalization of $28,625,236, and the projected volatility based on a historical value used of 93% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month. For the year ended December 31, 2012, the assumptions included the closing stock price of $1.74 per share, the total market capitalization of $71,338,556, and the projected volatility based on a historical value used of 182% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month.

	The following tabular presentation reflects the components of derivative financial instruments on the Company’s balance sheet at December 31, 2013 and December 31, 2012:

	Components of derivative financial instruments

		12/31/13	12/31/12
	Common stock warrants	$95,049	$6,626,255
	Embedded conversion features for
	convertible debt or preferred shares	-	1,399,126

	Total	$95,049	$8,025,381

	Beginning balance	$8,025,381	$11,031,432
	Change in derivative liability valuation	(966,736)	1,514,156
	Change in derivative liability - settlements	(6,963,596)	(4,520,207)

	Total	$95,049	$8,025,381

	For the twelve months ended December 31, 2013, the Company issued 5,893,887 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis. The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2,489,552 on the exercise dates. Finally, the Company issued 3,859,697 shares of common stock as a result of the conversion of Series II Convertible Preferred Stock and accrued dividends. The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2,761,688 on the conversion dates.

	As a result of the August 20, 2013 transaction with Brightline Ventures I, pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program, the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned, each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25. There were a total of 11,880,047 warrants that were not exercised as part of the Cashless Exercise Program. In addition, the warrant holders agreed to permanently waive the full reset feature contained in the original warrant. As a result, the Company issued an aggregate of 2,376,009 additional warrants at an exercise price of $1.25 per share (including 2,316,597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1,712,356.

	On November 18, 2013, the Company completed a public offering of 1,866,667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1,400,000 shares of Common Stock at an exercise price of $1.00 per share. The warrants were issued with a full reset feature which was valued at $57,729 at issuance and netted with the $966,736 gain recognized on the derivative liability for the year ended December 31, 2013.

	During 2012, the Company issued 689,087 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis. The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $1,021,913 on the exercise dates. Also during 2012, the Company issued 1,658,979 shares of common stock as a result of the conversion of the remaining 2008 and 2010 notes payable, including accrued interest. The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $48,619 on the conversion dates. Finally, the Company issued 5,493,912 shares of common stock as a result of the conversion of Series I Preferred Stock and accrued dividends. The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $3,449,675 on the conversion dates.

EQUITY

EQUITY	12 Months Ended
EQUITY	Dec. 31, 2013
EQUITY [Abstract]	'
EQUITY	'
	NOTE 12–EQUITY

	COMMON STOCK ISSUED FOR SERVICES IN 2012

	On February 6, 2012 the Company issued 238,800 shares of common stock to its four non-executive directors (59,700 each) – Mark Hershhorn, Brian Israel, Morris Garfinkle and Edward Smith III. The Company recognized a total of expense of $160,000 related to these issuances. These shares were valued based on the closing price of the grant date.

	On July 2, 2012, we entered into a Private Placement of Securities & Advisory Services Agreement with Maxim Group LLC, pursuant to which Maxim agreed to act as the Company’s exclusive placement agent in a proposed private placement of equity, convertible, debt and/or linked securities of the Company up to $10 million. This agreement terminated on December 31, 2012.

	In exchange for Maxim’s services, we agreed to pay Maxim with 150,000 shares of the Company’s Common Stock valued at $150,000 for purposes of the agreement, as well as $10,000 per month for the duration of this agreement. An additional 350,000 shares of Common Stock would have been issued to Maxim upon the completion of a closing that resulted in the Company receiving a minimum of $10 million. No such transaction occurred prior to the termination of the agreement.

	We determined that all of the securities issued pursuant to the agreement were exempt from registration under the Securities Act of 1933, as amended (the "Act") pursuant to Section 4(2) of the Act and Rule 506 of Regulation D promulgated under the Act. We based this determination on the non-public manner in which we offered the securities and on the representations of the persons purchasing such securities, which included, in pertinent part, that such persons were "accredited investors" within the meaning of Rule 501 of Regulation D promulgated under the Act, and that such persons were acquiring such securities for investment purposes for their own respective accounts and not as nominees or agents, and not with a view to resale or distribution, and that each such person understood such securities may not be sold or otherwise disposed of without registration under the Act or an applicable exemption therefrom.

	COMMON STOCK ISSUED FOR SERVICES IN 2013

	On January 22, 2013 the Company issued 114,944 shares of common stock to its four non-executive directors, Mark Hershhorn, Morris Garfinkle, Brian Israel and Edward Smith (28,736 shares each). The Company recognized a total of expense of $200,002 related to these issuances. These shares were valued based on the closing price on the grant date.

	On October 28, 2013, the Company entered into a Consulting Agreement with Steeltown Consulting Group, LLC, pursuant to which Steeltown will assist in evaluating various business and financial matters. The Company issued 220,000 restricted shares of common stock as consideration for the services being rendered in this agreement. This agreement was scheduled to terminate on January 31, 2014. On December 3, 2013, the Company and Steeltown entered into a new Consulting Agreement (which replaces the agreement dated October 28, 2013) in which both the Company and Steeltown substantially agreed to the same services being rendered as the previous agreement. The Company issued 550,000 shares of restricted common stock as consideration for the services being rendered under this new agreement. This agreement will terminate on January 31, 2015. The Common Stock was valued at $569,800 based on the closing prices of the stock on the dates the agreements were executed.

	COMMON STOCK ISSUED FOR DEBT CONVERSION

	On January 15, 2012, the Company issued 1,508,000 shares of its Common Stock, $.00005 par value per share, upon conversion to common stock of its 8% Convertible Secured Notes due in 2012 (the "Notes"), representing principal of $1,300,000 and interest of $208,000. The conversion was in accordance with the agreement, and therefore no gain or loss was recorded.

	On April 19, 2012, the Company issued 150,979 shares of its Common Stock, $.00005 par value per share, upon conversion to common stock of its Notes, representing principal of $120,000 and interest of $30,979. The conversion was in accordance with the agreement, and therefore no gain or loss was recorded.

	On November 5, 2012, the Company issued 212,056 shares of its Common Stock, $.00005 par value per share, upon conversion to common stock of its Notes, representing principal of $200,000 and interest of $12,056. The conversion was in accordance with the agreement, and therefore no gain or loss was recorded.

	COMMON STOCK ISSUED ON THE EXERCISE OF WARRANTS FOR CASH

	During the first quarter of 2013, several investors participated in a warrant exercise program that resulted in the exercise of 1,756,088 warrants into 1,756,088 shares of the Company’s common stock. The warrant program, which was open to all holders of $1.50 warrants, allowed those warrant holders to exercise their warrants for a $1.25 strike price during February 2013; it also required a waiver of the anti-dilution provisions in these warrants until February 28, 2013 so that those provisions would not be triggered by the exercises. The conversion of these warrants raised $2,195,110 of cash for the Company. As a result of this warrant modification the Company recognized $4,789,801 of additional expense for previously issued warrants during the period ended March 31, 2013. The value of the additional expense was based on the fair value of the warrant modification at the date the offer was made to the warrant holders calculated by using the Black-Scholes Model. The key inputs utilized in this model include the Company’s stock price on the date of the modification of $2.30, the computed volatility of the Company’s stock price at 109.96% and the discount rate used based on a U.S. Treasury security for a comparable period to the remaining term of the warrants of .06%.

	Also during 2013, in addition to the warrant exercise program described above, other investors exercised 531,642 warrants and the Company received proceeds of $294,736.

	During 2012, 490,424 stock warrants were exercised for cash of $304,225.

	COMMON STOCK ISSUED ON THE CASHLESS EXERCISE OF WARRANTS

	Beginning August 20, 2013 and in conjunction with the private placement subscription agreement entered into between the Company and Brightline Ventures I-C, LLC (indicated below and referred to as the “1.25 Raise”), the Company (i) allowed the holders of the Company’s outstanding warrants with a $1.50 per share exercise price (the “$1.50 Warrants”) with certain anti-dilution provisions contained in the related warrant agreements to choose to exercise their $1.50 Warrants on a cashless basis such that for every ten $1.50 Warrants exercised, the holder received 4.5 shares of Common Stock (fractional shares were rounded up) (the “Cashless Exercise Program”), (ii) sought a temporary waiver from the holders of the $1.50 Warrants of the anti-dilution provisions in the warrant agreements with respect to the Cashless Exercise Program and potential capital-raising activities (other than the $1.25 Raise) by the Company by December 31, 2013, and (iii) asked the holders of the $1.50 Warrants to permanently amend the warrant agreements with respect to certain ratchet provisions so as to reduce the derivative liability the Company incurs as a result of those provisions in the agreements.

	The Cashless Exercise Program resulted in 7,172,751 of the $1.50 Warrants being converted into 3,227,742 shares of the Company’s common stock (including 5,718,750 $1.50 Warrants that were converted by Brightline Ventures I into 2,573,438 shares of common stock). As a result of the Cashless Exercise Program, the Company recognized a loss on equity modification of $990,656—the difference in value between the $1.50 Warrants exercised and the common stock issued— for the three months ended September 30, 2013.

	As a result of the August 20, 2013 transaction with Brightline Ventures I, pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program, the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned, each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25. There were a total of 11,880,047 warrants that were not exercised as part of the Cashless Exercise Program. In addition, the warrant holders agreed to permanently waive the full reset feature contained in the original warrant. As a result, the Company issued an aggregate of 2,376,009 additional warrants at an exercise price of $1.25 per share (including 2,316,597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1,712,356.

	Also during 2013, in addition to the warrant exercise program described above, other investors exercised 909,784 warrants on a cashless basis and received 378,415 shares of common stock.

	During 2012, the Company issued 198,663 shares of common stock on the cashless exercise of warrants.

	COMMON STOCK ISSUED ON THE EXERCISE OF STOCK OPTIONS FOR CASH

	During 2013, two former employees exercised 91,400 stock options and the Company received proceeds of $77,734.

	During 2012, 14,600 stock options were exercised for cash of $9,526.

	COMMON STOCK ISSUED ON THE CASHLESS EXERCISE OF STOCK OPTIONS

	During 2013, the Company issued 100,528 shares of common stock on the cashless exercise of 202,250 stock options.

	During 2012, the Company issued 131,161 shares of common stock on the cashless exercise of options.

	COMMON STOCK ISSUED IN PRIVATE PLACEMENTS

	On August 20, 2013, the Company raised additional capital by entering into a private placement subscription agreement with Brightline Ventures I-C, LLC, an affiliate of its controlling stockholder, pursuant to which it sold 376,000 shares of common stock, for a price of $1.25 per share (the “1.25 Raise”), and received gross proceeds of $470,000.

	On September 18, 2013, the Company entered into another private placement subscription agreement with Brightline Ventures I-C, LLC, pursuant to which it sold 468,571 shares of Common Stock for a price of $1.05 per share, along with warrants to purchase 234,286 shares of common stock at an exercise price of $1.50 per share (the “1.05 Raise”), and received gross proceeds of $492,000. The waiver discussed above was effective for the $1.05 Raise; therefore, no additional warrants were issued and no exercise price adjustments were made pursuant to anti-dilution and ratchet provisions as a result of the $1.05 Raise.

COMMON STOCK ISSUED IN PUBLIC OFFERING

On November 18, 2013, the Company completed the sale of 1,866,667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1,400,000 shares of Common Stock at an exercise price of $1.00 per share. The Company received after deducting various transaction expenses, net proceeds of $1,210,165.

COMMON STOCK PAYABLE

On February 12, 2013, we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company. As a result of this agreement, the Company issued 875,000 shares of Common Stock to this party. As of December 31, 2012, the Company has recorded a common stock payable in the amount of $1,881,250 which is equal to the value of the shares on the settlement date.

CONVERTIBLE PREFERRED STOCK

As indicated previously, the Company entered into a modification with Brightline Ventures I pursuant to which Brightline Ventures I agreed to convert preferred stock into common stock on or before the respective maturity. As a result of this modification the Convertible, Redeemable Preferred Stock Series II was reclassified to equity as Convertible Preferred Stock Series II as of December 31, 2012 as the shares are no longer redeemable. On March 18, 2013, Brightline Ventures I converted the Series II Convertible Preferred Stock of $3,326,697 together with $533,000 of accrued dividends thereon into 3,859,697 shares of the Company’s Common Stock.

STOCK_OPTION_PLAN_AND_WARRANTS

STOCK OPTION PLAN AND WARRANTS	12 Months Ended
STOCK OPTION PLAN AND WARRANTS	Dec. 31, 2013
STOCK OPTION PLAN AND WARRANTS [Abstract]	'
STOCK OPTION PLAN AND WARRANTS	'
	NOTE 13 – STOCK OPTION PLAN AND WARRANTS

	EXERCISING OPTIONS AND WARRANTS

	For the twelve months ended December 31, 2013, there were 2,287,730 stock warrants were exercised for cash and the Company issued 3,606,157 shares of Common Stock on the cashless exercise of warrants. Also during 2013, 91,400 stock options were exercised for cash while the Company issued 100,528 shares of common stock on the cashless exercise of stock options. In 2012, 490,424 stock warrants were exercised for cash and the Company issued 198,663 shares of Common Stock for the cashless exercise of warrants. Also during 2012, 14,600 stock options were exercised for cash while the Company issued 131,161 shares of Common Stock on the cashless exercise of options.

	A summary of the status of the warrants issued by the Company as of December 31, 2013 and 2012 are as follows:

			12/31/13				12/31/12
			Number of Warrants		Weighted Average Exercise Price		Number of Warrants		Weighted Average Exercise Price
	Outstanding at beginning of year		23,392,811		$1.46		23,752,669		$1.55
	Granted		4,010,295		$1.18		650,000		$0.83
	Exercised		(2,287,730)		$1.28		(490,424)		$0.62
	Cashless Exercises		(8,082,535)		$1.43		(335,541)		$0.91
	Expired and Cancelled		(344,576)		$0.88		(183,893)		$14.73
			16,688,265				23,392,811

	Outstanding, end of period		16,688,265		$1.44		23,392,811		$1.46

	Exercisable at end of period		16,688,265		$1.44		23,392,811		$1.46

	As of December 31, 2013 and 2012, the Company had warrants outstanding to purchase 16,688,265 and 23,736,811 shares of the Company’s common stock, respectively, at prices ranging from $0.01 to $1.50 per share. These warrants expire at various dates through November 2018.

	There were 4,010,295 warrants issued in 2013. As part of the August 20, 2013 transaction with Brightline Ventures I discussed above, the Company issued one additional warrant equal for every five warrants owned and not exercised as part of the Cashless Exercise Program. Thus, the Company issued an aggregate of 2,376,009 additional warrants at an exercise price of $1.25 per share (including 2,316,597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants. On September 18, 2013, the Company entered into a private placement subscription agreement with Brightline Ventures I-C, LLC, pursuant to which it issued warrants to purchase 234,286 shares of common stock at an exercise price of $1.50 per share. Finally, On November 18, 2013, the Company completed a public offering of its Common Stock in which it issued warrants to purchase 1,400,000 shares of Common Stock at an exercise price of $1.00 per share.

	On October 21, 2013, the Company issued warrants to purchase up to 30,000 shares of common stock in a private placement transaction to a business consultant who will be assisting the Company in various product placement matters as partial consideration for services being rendered. The per share exercise prices of the warrants will be determined based on the market price of the Company’s common stock if and when certain targets are met; the warrants are exercisable through October 21, 2018.

	During 2012, there were 650,000 warrants issued to investors and for services rendered. The fair value of the warrants issued in 2012 did not have any reset provisions and were valued at $273,641 using the Black Scholes model. A portion of these warrants equal to 100,000, were valued at $40,508 and were attached to debt. These warrants were recorded as a debt discount upon issuance and were fully amortized upon conversion of the related notes in 2012. The other portion of warrants equal to 550,000, were valued at $233,133 using the Black Scholes model on the grant date. These warrants were issued for investor relations services. The fair value is being amortized straight line over the related requisite service period which resulted in $172,000 of expense during the year ended December 31, 2012.

	STOCK OPTION PLAN

	The Company’s Incentive Compensation Plan (the “Plan”) provides for the issuance of qualified options to all employees and non-qualified options to directors, consultants and other service providers.

	A summary of the status of stock options issued by the Company as of December 31, 2013 and 2012 are as follows:

			12/31/13				12/31/12
			Number of Shares		Weighted Average Exercise Price		Number of Shares		Weighted Average Exercise Price
	Outstanding at beginning of year		7,728,877		$1.01		5,645,202		$1.10
	Granted		2,176,535		$1.67		2,354,275		$0.80
	Exercised		(293,650)		$0.98		(230,600)		$1.09
	Expired and Cancelled		(28,000)		$2.18		(40,000)		$0.86
			9,583,762				7,728,877

	Outstanding, end of period		9,583,762		$1.16		7,728,877		$1.01


	Exercisable at end of period		9,536,262		$1.17		7,582,022		$1.03

	At December 31, 2013, the aggregate intrinsic value of all outstanding options was $0 of which 9,536,262 outstanding options are currently exercisable at a weighted average exercise price of $1.17 and a weighted average remaining contractual term of 3.3 years.

	The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes option valuation model. This model uses the assumptions listed in the table below. Expected volatilities are based on the historical volatility of the Company’s stock. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

		2013		2012
	Weighted average fair value per option granted	$1.04		$0.38
	Risk-free interest rate	0.65 - 0.81%		0.34 - 0.42%
	Expected dividend yield	0.00%		0.00%
	Expected lives	2.695		2.695
	Expected volatility	99.79 - 108%		97.72 - 103%

	During 2013, the Company granted 2,176,535 options to employees and recognized a total of $2,318,355 in stock compensation expense. During 2012, the Company granted 2,324,275 options to employees or advisors and recognized a total of $96,599 in stock based compensation related to the options granted above. The options granted to employees are 25% vested at the date of grant and 25% every 90, 180 and 270 days subsequent to the grant date. The expiration date of the options granted in both 2013 and 2012 is five years from the grant date.

	As of December 31, 2013, the Company had reserved 8,416,238 shares of Common Stock to be issued upon the exercise of qualified options issued under the Plan. As of December 31, 2012 the Company had 10,271,123 shares available for grant under the Plan.

Stock options outstanding at December 31, 2013 are as follows:

				Weighted
				Average		Weighted
				Remaining		Average
		Options		Contractual		Exercise		Options
Range of Exercise Prices		Outstanding		Life		Price		Exercisable
$0.01-$1.50		7,090,227		2.8		$0.97		7,090,227
$1.51-$3.00		2,368,535		4.5		$1.67		2,321,035
$3.01-$5.00		125,000		4.6		$3.11		125,000
		9,583,762		3.3		$1.17		9,536,262


Stock options outstanding at December 31, 2012 are as follows:

				Weighted
				Average		Weighted
				Remaining		Average
		Options		Contractual		Exercise		Options
Range of Exercise Prices		Outstanding		Life		Price		Exercisable
$0.01-$1.50		5,435,202		3.9		$1.18		5,107,003
$1.51-$3.00		210,000		2.0		$1.49		210,000
		5,645,202		4.0		1.13		5,317,003

As of December 31, 2013 and 2012 the Company had unrecognized stock based compensation to be recognized in the following year of $22,103 and $77,595, respectively.

SETTLEMENT_LOSSES

SETTLEMENT LOSSES	12 Months Ended
SETTLEMENT LOSSES	Dec. 31, 2013
SETTLEMENT LOSSES [Abstract]	'
SETTLEMENT LOSSES	'
	NOTE 14 – SETTLEMENT LOSSES

	In December 2011, the Company was sued in Circuit Court of the 17th Judicial District, Winnebago County, Illinois, by LIBCO Industries, Inc., alleging the Company breached a construction contract and tortuously interfered with a business relationship, and is seeking damages in excess of $185,000. The case has subsequently been transferred to the 19th Judicial Circuit Court, Lake County, Illinois. Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim. Related to this matter, Process Piping, LLC, a sub-contractor for LIBCO Industries, filed a mechanics lien on the property leased by the Company, claiming it was owed in excess of $95,000 by LIBCO Industries. As of December 31, 2011, the Company accrued as a settlement loss, the $62,500 paid to Process Piping, LLC on March 6, 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries. On January 31, 2013, the Circuit Court granted the Company’s motion for partial summary judgment on the tortious interference claim. In the fourth quarter of 2013, the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement, the Company received $10,000 in cash and both parties provided releases of all respective claims.

	During 2012, the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission. The Company settled with a payment of $13,968 and the matter was resolved.

	As of December 31, 2012, the Company has recorded a liability in the amount of $102,000 relating to the complaint initiated by Joseph Sanfilippo and James Cluck as discussed in Note 18 below. The Company believes that it has good grounds to defend this suit, and has only allocated this amount so as to be compliant with applicable accounting standards.

	On February 12, 2013, we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company. As a result of this agreement, the Company issued 875,000 shares of Common Stock to this party. As of December 31, 2012, the Company has recorded a common stock payable and settlement loss in the amount of $1,881,250.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2013
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 15 – INCOME TAXES

	During 2013 and 2012, the Company incurred net losses, and therefore had no tax liability. The net deferred tax asset generated by the loss carry forward has been fully reserved. The cumulative net loss carry forward is approximately $96,624,455 and $91,147,205 for the years ended December 31, 2013 and 2012 respectively, and will expire in the years 2021 through 2033.

	At December 31, 2013, the net deferred tax asset based on a 34% tax rate consisted of the following:


		12/31/13	12/31/12

	Net operating loss	$32,852,315	$30,990,050

	Less: Valuation allowance	(32,852,315)	(30,990,050)

	Net deferred tax asset	$-	$-

	After evaluating our own potential tax uncertainties, the Company has determined that there are no material uncertain tax positions that have a greater than 50% likelihood of reversal if the Company were to be audited. Our tax returns for the years ended December 31, 2013 and 2012 may be subject to IRS audit.

MAJOR_CUSTOMERS_AND_CONCENTRAT

MAJOR CUSTOMERS AND CONCENTRATIONS	12 Months Ended
MAJOR CUSTOMERS AND CONCENTRATIONS	Dec. 31, 2013
MAJOR CUSTOMERS AND CONCENTRATIONS [Abstract]	'
MAJOR CUSTOMERS AND CONCENTRATIONS	'
	NOTE 16 – MAJOR CUSTOMERS AND CONCENTRATIONS

	The Company’s customers are food manufacturers, school districts and the general public. There were three significant customers who accounted for 36%, 24% and 5% of total sales for the year ended December 31, 2013. There were three significant customers who accounted for 36%, 24% and 9% of total sales for the year ended December 31, 2012. Further, two significant customers accounted for 61% and 11% of the total accounts receivable for the year ended December 31, 2013. Two significant customers accounted for 77% and 9% of the total accounts receivable for the year ended December 31, 2012.

	The Company maintains cash deposits with major banks, which from time to time may exceed federally insured limits. At December 31, 2013 and 2012, $193,472 and $394,804, respectively, were in excess of federally insured limits. The Company periodically assesses the financial condition of the institutions and believes that the risk of any loss is minimal.

COMMITMENTS

COMMITMENTS	12 Months Ended
	Dec. 31, 2013
COMMITTMENTS [Abstract]	'
COMMITTMENTS	'
	NOTE 17 – COMMITTMENTS

	Building Lease

	The Company leases a combined production and office facility located in Mundelein, Illinois. The facility is approximately 44,000 square feet. The Company extended the lease in the first quarter of 2013 until May 2014 and the required monthly rental payments will be $21,361, including property taxes. Insurance and maintenance are billed when due. If we were to lose this lease or not be able to extend our lease due to the specific requirements of our Company, the effect on our operations could be substantial.

	The Company recognizes escalating lease expense on a straight-line basis in accordance with current accounting standards.

	The future minimum annual rental payments and sub-lease income for the years ended December 31 under the lease terms are as follows:


	Year Ended	Rentals
	2014	256,332
	2015	85,444
	2016	-
	2017	-
	2018	-
		$341,776


	The total rent expense for the years ended December 31, 2013 and 2012, respectively, was $280,696 and $324,397.

	On March 14, 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein, Illinois. The amendment extended the term of the lease to May 14, 2015 upon the same terms and conditions contained in the lease as amended.

LITIGATION_CONTINGENT_LIABILIT

LITIGATION/ CONTINGENT LIABILITY	12 Months Ended
LITIGATION/ CONTINGENT LIABILITY	Dec. 31, 2013
LITIGATION/ CONTINGENT LIABILITY [Abstract]	'
LITIGATION/ CONTINGENT LIABILITY	'
	NOTE 18– LITIGATION/ CONTINGENT LIABILITY

	On July 7, 2007, the Company was served with a complaint by Joseph Sanfilippo and James Cluck for violation of the Consumer Fraud Act and is seeking damages in excess of $200,000. The trial court has issued a default order against the Company, and has denied the Company’s Motion to reconsider. Management believes that the trial court’s rulings were erroneous and that it has grounds for appeal, and that the underlying allegations are frivolous and wholly without merit and will vigorously defend the claim. The outcome of this matter is unknown as of the report date. However, the Company has conservatively allocated a reserve of $102,000 to satisfy any liability it may incur as a result of this matter.

	In December 2011, the Company was sued in Circuit Court of the 17th Judicial District, Winnebago County, Illinois, by LIBCO Industries, Inc., alleging the Company breached a construction contract and tortuously interfered with a business relationship, and is seeking damages in excess of $185,000. The case has subsequently been transferred to the 19th Judicial Circuit Court, Lake County, Illinois. Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim. Related to this matter, Process Piping, LLC, a sub-contractor for LIBCO Industries, filed a mechanics lien on the property leased by the Company, claiming it was owed in excess of $95,000 by LIBCO Industries. As of December 31, 2011, the Company accrued as a settlement loss, the $62,500 paid to Process Piping, LLC on March 6, 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries. On January 31, 2013, the Circuit Court granted the Company’s motion for partial summary judgment on the tortious interference claim. In the fourth quarter of 2013, the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement, the Company received $10,000 in cash and both parties provided releases of all respective claims.

	During 2012, the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission. The Company settled with a payment of $13,968 and the matter was resolved.

GUARANTEES

GUARANTEES	12 Months Ended
GUARANTEES	Dec. 31, 2013
GUARANTEES [Abstract]	'
GUARANTEES	'
	NOTE 19 – GUARANTEES

	The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third party claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company's officers, directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship. The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on its balance sheet as of December 31, 2013.

	In general, the Company offers a one-year warranty for most of the products it sold. To date, the Company has not incurred any material costs associated with these warranties.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
RELATED PARTY TRANSACTIONS	Dec. 31, 2013
RELATED PARTY TRANSACTIONS [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	NOTE 20 – RELATED PARTY TRANSACTIONS

	On February 6, 2012 the Company issued 238,800 shares of common stock to its four non-executive directors (59,700 each) – Mark Hershhorn, Brian Israel, Morris Garfinkle and Edward Smith III. The Company recognized a total expense of $160,000 related to these issuances. These shares were valued based on the closing price of the grant date.
	On August 15, 2012, Morris Garfinkle, a Director of the Company, converted $34,800 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 34,800 shares of the Company’s Common Stock.

	On December 11, 2012, the Company’s external Directors, Mark Hershhorn, Morris Garfinkle, Brian Israel and Edward Smith each agreed to convert $17,403 (including accrued dividends) of Series I Convertible, Redeemable Preferred Stock into 17,403 shares of the Company’s Common Stock prior to its maturity. The aggregate conversion by the directors was $69,612. As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31, 2012.

	On January 22, 2013 the Company issued 114,944 shares of common stock to its four non-executive directors, Mark Hershhorn, Morris Garfinkle, Brian Israel and Edward Smith (28,736 shares each). The Company recognized a total of expense of $200,002 related to these issuances. These shares were valued based on the closing price on the grant date.

	On February 27, 2013 Morris Garfinkle, a Director of the Company, participated in a warrant exercise program in which all holders of $1.50 warrants were allowed to exercise their warrants for a $1.25 strike price during February 2013. Mr. Garfinkle exercised 200,000 warrants and received 200,000 shares of Common Stock. As a result of this warrant modification the Company recognized $45,596 of additional expense during the quarter ended March 31, 2013 relating to Mr. Garfinkle’ s warrants based on the fair value of the warrant modification at the date the offer was made to all warrant holders calculated by using the Black-Scholes Model. On March 6, 2013, Mr. Garfinkle exercised other warrants, with various exercise prices, and received 26,571 shares of Common Stock. During August 2013, Mark Hershhorn, Edward Smith and Brian Israel, Directors of the Company, participated in a warrant exercised program offered to all holders of $1.50 warrants such that each warrant holder, on a cashless basis, can receive 4.5 shares of Common Stock for every ten warrants exercised. Messrs. Hershhorn, Smith and Israel, in the aggregate, exercised 127,695 warrants and received 58,395 shares of Common Stock. As a result of the warrant modification the Company recognized $24,281 of additional expense during the quarter ended September 30, 2013 relating to the difference in value between the $1.50 warrants exercised by Messrs. Hershhorn, Smith and Israel and the Common Stock issued.

	See also Notes 9 and 12 with respect to transactions involving our largest shareholder, Brightline Ventures I, LLC.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2013
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 21 – SUBSEQUENT EVENTS

	On January 2, 2014 the Company issued 285,716 shares of common stock to its four non-executive directors (71,429 each) – Mark Hershhorn, Brian Israel, Morris Garfinkle and Edward Smith III. The Company recognized a total expense of $160,001 related to these issuances. These shares were valued based on the closing price on the grant date.

	On February 11, 2014 the Company entered into an agreement with Edward Smith III, a Director and Shareholder of the Company, pursuant to which Mr. Smith agreed to lend the Company $200,000 in a convertible senior secured note. The note matures in two years (February 11, 2016) and bears interest at 12.5% computed based on a 365-day year. Accrued interest is payable either at maturity or quarterly at the option of Mr. Smith in shares of the Company’s Common Stock. The note is substantially secured by the assets of the Company.

	On March 14, 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein, Illinois. The amendment extended the term of the lease from March 15, 2014 to May 14, 2015 upon the same terms and conditions contained in the lease as amended.

	On March 24, 2014, Fordham Capital Partners, LLC (“Fordham”) extended a $500,000 revolving loan (the “Equipment Loan”) to Z Trim Holdings, Inc. (the “Company”) evidenced by an Equipment Revolving Note (the “Note”) issued by the Company to Fordham. The Note requires monthly payments of principal of $10,417 plus interest, commencing on April 24, 2014 and continuing until February 24, 2015, followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24, 2015. The interest on the Note is calculated at a fixed rate of 20% per annum. The Note may be prepaid in full at any time; provided that if the Company prepays the Note prior to September 24, 2014 (such six-month period, the “Guaranteed Interest Period”), it must pay a prepayment penalty equal to the amount by which (i) the aggregate interest that Fordham would have received on the Note during the Guaranteed Interest Period had there been no prepayment exceeds (ii) the aggregate interest paid by the Company prior to the date of prepayment.

	Pursuant to the Security Agreement, dated March 24, 2014, between the Company and Fordham (the “Security Agreement”), the Equipment Loan is secured by all of the Company’s equipment (as more specifically defined in the Security Agreement, the “Collateral”). The Security Agreement also contains customary restrictive covenants, including without limitation, covenants prohibiting the Company from (i) granting additional liens in the Collateral, (ii) selling, leasing or transferring the Collateral, (iii) entering into certain merger, consolidation or other reorganization transactions, and (iv) creating, incurring or assuming additional indebtedness, in each case subject to certain exceptions. The Security Agreement also contains customary events of default. If an event of default under the Security Agreement occurs and is continuing, Fordham may declare any outstanding obligations under the Credit Agreement immediately due and payable. After an event of default, interest on the Note would accrue at a rate of 25% per annum.

	Additionally, pursuant to the Factoring Agreement, dated March 24, 2014, between the Company and Fordham, Fordham may purchase any Accounts of the Company (the “Factoring Agreement”). To secure payment and performance of the Company’s liabilities and obligations to Fordham, including obligations under the Factoring Agreement, the Company granted Fordham a security interest in all of the Company’s (i) Accounts, (ii) Inventory, (iii) Chattel Paper, Deposit Accounts, Documents, Equipment, Financial Assets, Fixtures, General Intangibles, Instruments, Investment Property, Letter-of-Credit Rights, Securities, Software and Supporting Obligations, (iv) books and records of Seller which relate to Accounts, (v) all amounts owing to the Company under the Factoring Agreement, and (vi) Proceeds of the foregoing. The Factoring Agreement terminates at any time that the Equipment Loan is paid in full.

	On March 28, 2014 the Company entered into an amendment to the custom processing agreement with Aveka Nutra Processing LLC relating to the repayment of the line of credit advances made by the Company plus interest. Commencing on April 1, 2014, Aveka Nutra Processing agreed to begin paying the Company $5,000 per month to be applied to the advances made and accrued interest.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Use of Estimates	'
	Use of Estimates

	The preparation of the accompanying financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	'
	Revenue Recognition

	The Company generally recognizes product revenue when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable. In instances where the final acceptance of the product is specified by the customer, revenue is deferred until all acceptance criteria have been met. No provisions were established for estimated product returns and allowances based on the Company’s historical experience.
Allowance for Doubtful Accounts	'
	Allowance for Doubtful Accounts


	Management of the Company makes judgments as to its ability to collect outstanding receivables and provide allowances for the portion of receivables when collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding invoices. For those invoices not specifically reviewed, provisions are provided at differing rates, based upon the age of the receivable. In determining these percentages, management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables, additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31, 2013 and 2012, the allowance for doubtful accounts was $0.
Cash and cash equivalents	'
	Cash and cash equivalents

	For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. There were no cash equivalents as of December 31, 2013 and 2012.
Inventory	'
	Inventory

	Inventory is stated at the lower of cost or market, using the first-in, first-out method. The Company follows standard costing methods for manufactured products.
Property and Equipment	'
	Property and Equipment

	Property and equipment are stated at cost less accumulated depreciation and amortization. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Estimated useful lives of five to ten years are used for machinery and equipment, office equipment and furniture, and automobile. Estimated useful lives of up to five years are used for computer equipment and related software. Depreciation and amortization of leasehold improvements are computed using the term of the lease.
Intangible Assets	'
	Intangible Assets

	Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally from fifteen to twenty years.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets

	Long-lived assets and certain identifiable intangible assets to be held and used are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of such assets may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. Measurement of an impairment loss for long-lived assets and certain identifiable intangible assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets and certain identifiable intangible assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.
Income Taxes	'
	Income Taxes

	The amount of current and deferred taxes payable or refundable is recognized as of the date of the financial statements, utilizing currently enacted tax laws and rates. Deferred tax expenses or benefits are recognized in the financial statements for the changes in deferred tax liabilities or assets between years.
Accounting for Derivative Instruments	'
	Accounting for Derivative Instruments

	All derivatives have been recorded on the balance sheet at fair value based on the lattice model calculation. These derivatives, including embedded derivatives in the Company’s warrants, convertible preferred stock, and its Convertible 8% Senior Secured Notes issued in 2008, 2009, and 2010, which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes, are separately valued and accounted for on the Company’s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.
Lattice Valuation Model	'
	Lattice Valuation Model

	The Company valued the warrants and conversion features in their convertible notes and preferred stock using a lattice valuation model, with the assistance of a valuation consultant. The lattice model values these instruments based on a probability weighted discounted cash flow model. The Company uses the model to develop a set of potential scenarios. Probabilities of each scenario occurring during the remaining term of the instruments are determined based on management's projections and the expert’s calculations. These probabilities are used to create a cash flow projection over the term of the instruments and determine the probability that the projected cash flow will be achieved. A discounted weighted average cash flow for each scenario is then calculated and compared to the discounted cash flow of the instruments without the compound embedded derivative in order to determine a value for the compound embedded derivative.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments

	The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, inventory, accounts payable and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.

	The Company utilizes various types of financing to fund its business needs, including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and, if so, whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31, 2013 and 2012, the Company had warrants to purchase common stock, the fair values of which are classified as a liability.
	Inputs used in the valuation to derive fair value are classified based on a fair value hierarchy which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

	- Level one — Quoted market prices in active markets for identical assets or liabilities;
	- Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
	- Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

	Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31, 2013 and 2012 was $95,049 and $8,025,381, respectively. The gain on derivative liability for the twelve months ended December 31, 2013 was $966,736 compared to a loss on derivative liability of $1,514,156 for the twelve months ended December 31, 2012. Below is a hierarchy table of the components of the derivative liability:

		Carrying	Fair Value Measurements Using
		Value	Level 1	Level 2	Level 3	Total

	Derivative Liabilities
	12/31/11	$11,031,432	$-	$-	$11,031,432	$11,031,432

	Change in derivative liabilities due to
	settlements	(4,520,207)	-	-	(4,520,207)	(4,520,207)
	Change in derivative liabilities valuation	1,514,156	-	-	1,514,156	1,514,156
		(3,006,051)	-	-	(3,006,051)	(3,006,051)

	Derivative Liabilities
	12/31/12	$8,025,381	$-	$-	$8,025,381	$8,025,381

	Change in derivative liabilities due to
	settlements	(6,963,596)	-	-	(6,963,596)	(6,963,596)
	Change in derivative liabilities valuation	(966,736)	-	-	(966,736)	(966,736)
		(7,930,332)	-	-	(7,930,332)	(7,930,332)

	Derivative Liabilities
	12/31/13	$95,049	$-	$-	$95,049	$95,049
Accounting for Convertible, Redeemable Preferred Stock	'
	Accounting for Convertible, Redeemable Preferred Stock

	The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company’s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense, and discounts on instruments classified within permanent or temporary equity are amortized to retained earnings or additional paid in capital when there is an accumulated deficit. Amortization of discounts on preferred shares classified within equity or temporary equity is deducted from net income to common shareholders on the income statement.
Advertising Costs	'
	Advertising Costs

	The Company expenses all advertising costs as incurred. The amount for the year ended December 31, 2013 and 2012 was $250 and $18,425 respectively.
Income (Loss) Per Common Share	'
	Income (Loss) Per Common Share

	Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common stock outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding and, when diluted, potential shares from options and warrants to purchase common stock using the treasury stock method. Diluted net loss per common share does not differ from basic net loss per common share since potential shares of common stock are anti-dilutive for all periods presented.
Cashless Exercise of Warrants/Options	'
	Cashless Exercise of Warrants/Options

	The Company has issued warrants and options to purchase common stock where the holder is entitled to exercise via a cashless exercise. The Company accounts for the issuance of common stock on the cashless exercise of warrants and options on a net basis.
Stock-Based Compensation	'
	Stock-Based Compensation

	The Company estimates the fair value of share-based payment awards made to employees and directors, including stock options, restricted stock and employee stock purchases related to employee stock purchase plans, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods. We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2,318,355 and $1,547,826 for the years ended December 31, 2013 and 2012, respectively.
Notes Receivable	'
	Note Recievable

	The Company has entered into a custom processing agreement with a vendor in order to provide the Company with a partner for future manufacturing initiatives. The Company has agreed to make available a $500,000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75,000 during any thirty day period. The Company will be re-paid for these advances with future discounts on products manufactured by the vendor.

	The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account, and will be realized with future discounts as well.

	On March 28, 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest. Commencing on April 1, 2014, Aveka Nutra Processing will begin paying the Company $5,000 per month to be applied to advances and accrued interest.
New Accounting Pronouncements	'
	New Accounting Pronouncements

	Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income

	In February 2013, the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented, or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides, subject to certain conditions, the option to perform a qualitative, rather than quantitative, assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company’s financial position, results of operations or cash flows.

	Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists

	In July 2013, the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. The update will be effective in the first quarter of 2014, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

	Testing Indefinite-Lived Intangible Assets for Impairment

	In July 2012, the FASB issued an accounting standards update which provides, subject to certain conditions, the option to perform a qualitative, rather than quantitative, assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013, although early adoption is permitted, the Company has not elected early adoption of this pronouncement. The update may, under certain circumstances, reduce the complexity and costs of testing indefinite-lived intangible assets for impairment, but did not have a material impact on the Company’s financial position, results of operations or cash flows.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Schedule of components of the derivative liability	'
	Below is a hierarchy table of the components of the derivative liability:

		Carrying	Fair Value Measurements Using
		Value	Level 1	Level 2	Level 3	Total

	Derivative Liabilities
	12/31/11	$11,031,432	$-	$-	$11,031,432	$11,031,432

	Change in derivative liabilities due to
	settlements	(4,520,207)	-	-	(4,520,207)	(4,520,207)
	Change in derivative liabilities valuation	1,514,156	-	-	1,514,156	1,514,156
		(3,006,051)	-	-	(3,006,051)	(3,006,051)

	Derivative Liabilities
	12/31/12	$8,025,381	$-	$-	$8,025,381	$8,025,381

	Change in derivative liabilities due to
	settlements	(6,963,596)	-	-	(6,963,596)	(6,963,596)
	Change in derivative liabilities valuation	(966,736)	-	-	(966,736)	(966,736)
		(7,930,332)	-	-	(7,930,332)	(7,930,332)

	Derivative Liabilities
	12/31/13	$95,049	$-	$-	$95,049	$95,049

INVENTORY_Tables

INVENTORY (Tables)	12 Months Ended
INVENTORY (Tables)	Dec. 31, 2013
INVENTORY [Abstract]	'
Summary of inventory	'
	At December 31, inventory consists of the following:

		12/31/13	12/31/12
	Raw materials	$27,575	$42,831
	Packaging	8,178	1,873
	Work-in-process	33,527	64,170
	Finished goods	475,255	360,428

		$544,535	$469,30

PROPERTY_AND_EQUIPMENT_NET_Tab

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
PROPERTY AND EQUIPMENT, NET (Tables)	Dec. 31, 2013
PROPERTY AND EQUIPMENT, NET [Abstract]	'
Property and equipment, net	'
	At December 31, property and equipment, net consists of the following:

		12/31/13	12/31/12
	Production, engineering and other equipment	$6,422,110	$6,426,432
	Leasehold improvements	2,904,188	2,904,188
	Office equipment and furniture	603,182	603,182
	Computer equipment and related software	140,238	140,238
		$10,069,718	$10,074,040
	Accumulated depreciation	($8,269,412)	($7,628,075)
	Property and equipment, net	$1,800,306	$2,445,965

ACCRUED_EXPENSES_Tables

ACCRUED EXPENSES (Tables)	12 Months Ended
ACCRUED EXPENSES (Tables)	Dec. 31, 2013
ACCRUED EXPENSES [Abstract]	'
Accrued expenses and other	'
	At December 31, accrued expenses consist of the following:

		12/31/13	12/31/12
	Accrued payroll and taxes	$51,566	$32,021
	Accrued settlements	102,000	110,000
	Accrued expenses and other	40,578	31,513

		$194,144	$173,534

DERIVATIVE_LIABILITIES_Tables

DERIVATIVE LIABILITIES (Tables)	12 Months Ended
DERIVATIVE LIABILITIES (Tables)	Dec. 31, 2013
DERIVATIVE LIABILITIES [Abstract]	'
Components of derivative financial instruments	'
	The following tabular presentation reflects the components of derivative financial instruments on the Company’s balance sheet at December 31, 2013 and December 31, 2012:

	Components of derivative financial instruments

		12/31/13	12/31/12
	Common stock warrants	$95,049	$6,626,255
	Embedded conversion features for
	convertible debt or preferred shares	-	1,399,126

	Total	$95,049	$8,025,381

	Beginning balance	$8,025,381	$11,031,432
	Change in derivative liability valuation	(966,736)	1,514,156
	Change in derivative liability - settlements	(6,963,596)	(4,520,207)

	Total	$95,049	$8,025,381

STOCK_OPTION_PLAN_AND_WARRANTS1

STOCK OPTION PLAN AND WARRANTS (Tables)	12 Months Ended
STOCK OPTION PLAN AND WARRANTS (Tables)	Dec. 31, 2013
STOCK OPTION PLAN AND WARRANTS [Abstract]	'
Summary of warrant activity	'
	A summary of the status of the warrants issued by the Company as of December 31, 2013 and 2012 are as follows:

			12/31/13			12/31/12
			Number of Warrants		Weighted Average Exercise Price	Number of Warrants	Weighted Average Exercise Price
	Outstanding at beginning of year		23,392,811		$1.46	23,752,669	$1.55
	Granted		4,010,295		$1.18	650,000	$0.83
	Exercised		(2,287,730)		$1.28	(490,424)	$0.62
	Cashless Exercises		(8,082,535)		$1.43	(335,541)	$0.91
	Expired and Cancelled		(344,576)		$0.88	(183,893)	$14.73
			16,688,265			23,392,811

	Outstanding, end of period		16,688,265		$1.44	23,392,811	$1.46

	Exercisable at end of period		16,688,265		$1.44	23,392,811	$1.46
Summary of the status of stock options	'
	A summary of the status of stock options issued by the Company as of December 31, 2013 and 2012 are as follows:

			12/31/13			12/31/12
			Number of Shares		Weighted Average Exercise Price	Number of Shares	Weighted Average Exercise Price
	Outstanding at beginning of year		7,728,877		$1.01	5,645,202	$1.10
	Granted		2,176,535		$1.67	2,354,275	$0.80
	Exercised		(293,650)		$0.98	(230,600)	$1.09
	Expired and Cancelled		(28,000)		$2.18	(40,000)	$0.86
			9,583,762			7,728,877

	Outstanding, end of period		9,583,762		$1.16	7,728,877	$1.01


	Exercisable at end of period		9,536,262		$1.17	7,582,022	$1.03
Stock option valuation assumptions	'
		2013		2012
	Weighted average fair value per option granted	$1.04		$0.38
	Risk-free interest rate	0.65 - 0.81%		0.34 - 0.42%
	Expected dividend yield	0.00%		0.00%
	Expected lives	2.695		2.695
	Expected volatility	99.79 - 108%		97.72 - 103%
Stock options outstanding by price range	'
	Stock options outstanding at December 31, 2013 are as follows:

					Weighted
					Average	Weighted
					Remaining	Average
			Options		Contractual	Exercise	Options
	Range of Exercise Prices		Outstanding		Life	Price	Exercisable
	$0.01-$1.50		7,090,227		2.8	$0.97	7,090,227
	$1.51-$3.00		2,368,535		4.5	$1.67	2,321,035
	$3.01-$5.00		125,000		4.6	$3.11	125,000
			9,583,762		3.3	$1.17	9,536,262


	Stock options outstanding at December 31, 2012 are as follows:

					Weighted
					Average	Weighted
					Remaining	Average
			Options		Contractual	Exercise	Options
	Range of Exercise Prices		Outstanding		Life	Price	Exercisable
	$0.01-$1.50		5,435,202		3.9	$1.18	5,107,003
	$1.51-$3.00		210,000		2.0	$1.49	210,000
			5,645,202		4.0	1.13	5,317,003

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2013
INCOME TAXES [Abstract]	'
Net deferred tax asset	'
	At December 31, 2013, the net deferred tax asset based on a 34% tax rate consisted of the following:


		12/31/13	12/31/12

	Net operating loss	$32,852,315	$30,990,050

	Less: Valuation allowance	(32,852,315)	(30,990,050)

	Net deferred tax asset	$-	$

COMMITMENTS_Tables

COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
COMMITTMENTS [Abstract]	'
Future minimum annual rental payments and sub-lease income	'
	The future minimum annual rental payments and sub-lease income for the years ended December 31 under the lease terms are as follows:


	Year Ended	Rentals
	2014	256,332
	2015	85,444
	2016	-
	2017	-
	2018	-
		$341,776

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts [Abstract]	'	'
Allowance for doubtful accounts	$0	$0
Cash and cash equivalents [Abstract]	'	'
Cash equivalents	0	0
Accounting for Derivative Instruments [Abstract]	'	'
Interest rate on convertible senior secured notes (in hundredths)	8.00%	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Change in derivative liabilities valuation	-966,736	1,514,156
Advertising Costs [Abstract]	'	'
Advertising costs	250	18,425
Stock-Based Compensation [Abstract]	'	'
Compensation expense related to stock options	2,318,355	1,547,826
Custom Processing Agreement [Member] \| Note Receivable [Member]	'	'
Guarantor Obligations [Line Items]	'	'
Amount made available to vendor	500,000	'
Interest rate (in hundredths)	5.50%	'
Credit drawn down, maximum per period	75,000	'
Drawdown period threshold	'30 days	'
Periodic collections of advances and accrued interest	5,000	'
Fair Value, Measurements, Recurring [Member] \| Derivative Financial Instruments, Liabilities [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Derivative Liabilities, beginning of period	8,025,381	11,031,432
Change in derivative liabilities due to settlements	-6,963,596	-4,520,207
Change in derivative liabilities valuation	-966,736	1,514,156
Total change in derivative liabilities	-7,930,332	-30,060,501
Derivative Liabilities, end of period	95,049	8,025,381
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Derivative Financial Instruments, Liabilities [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Derivative Liabilities, beginning of period	0	0
Change in derivative liabilities due to settlements	0	0
Change in derivative liabilities valuation	0	0
Total change in derivative liabilities	0	0
Derivative Liabilities, end of period	0	0
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Derivative Financial Instruments, Liabilities [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Derivative Liabilities, beginning of period	0	0
Change in derivative liabilities due to settlements	0	0
Change in derivative liabilities valuation	0	0
Total change in derivative liabilities	0	0
Derivative Liabilities, end of period	0	0
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Derivative Financial Instruments, Liabilities [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Derivative Liabilities, beginning of period	8,025,381	11,031,432
Change in derivative liabilities due to settlements	-6,963,596	-4,520,207
Change in derivative liabilities valuation	-966,736	1,514,156
Total change in derivative liabilities	-7,930,332	-30,060,501
Derivative Liabilities, end of period	$95,049	$8,025,381
Minimum [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Estimated useful lives	'15 years	'
Maximum [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Estimated useful lives	'20 years	'
Machinery and Equipment [Member] \| Minimum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'5 years	'
Machinery and Equipment [Member] \| Maximum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'10 years	'
Office Equipment and Furniture [Member] \| Minimum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'5 years	'
Office Equipment and Furniture [Member] \| Maximum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'10 years	'
Automobiles [Member] \| Minimum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'5 years	'
Automobiles [Member] \| Maximum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'10 years	'
Computer Equipment and Related Software [Member] \| Maximum [Member]	'	'
Property and Equipment [Line Items]	'	'
Estimated useful lives	'5 years	'

INVENTORY_Details

INVENTORY (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
INVENTORY [Abstract]	'	'
Raw materials	$27,575	$42,831
Packaging	8,178	1,873
Work-in-process	33,527	64,170
Finished goods	475,255	360,428
Total inventory	544,535	469,302
Inventory valuation reserve	$742,168	'

PROPERTY_AND_EQUIPMENT_NET_Det

PROPERTY AND EQUIPMENT, NET (Details) (USD $)	12 Months Ended
PROPERTY AND EQUIPMENT, NET (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property and Equipment [Line Items]	'	'
Property and equipment, gross	$10,069,718	$10,074,040
Accumulated depreciation	-8,269,412	-7,628,075
Property and equipment, net	1,800,306	2,445,965
Depreciation expense	643,575	682,134
Net book value of assets sold	2,084	60,899
Cash proceeds from sale of assets	750	110,000
Gain (Loss) on sale	-1,334	49,101
Production, Engineering and Other Equipment [Member]	'	'
Property and Equipment [Line Items]	'	'
Property and equipment, gross	6,422,110	6,426,432
Leasehold Improvements [Member]	'	'
Property and Equipment [Line Items]	'	'
Property and equipment, gross	2,904,188	2,904,188
Office Equipment and Furniture [Member]	'	'
Property and Equipment [Line Items]	'	'
Property and equipment, gross	603,182	603,182
Computer Equipment and Related Software [Member]	'	'
Property and Equipment [Line Items]	'	'
Property and equipment, gross	$140,238	$140,238

NOTE_RECEIVABLE_Details

NOTE RECEIVABLE (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
	lb
Accounts, Notes, Loans and Financing Receivable [Line Items]	'
Initial term of custom processing agreement	'3 years
Renewal term of custom processing agreement	'2 years
Monthly minimum production requirements (in lbs.)	40,000
Average minimum monthly production volumes (in lbs.)	100,000
Future monthly production volume requirements, maximum (in lbs.)	1,000,000
Specified quantity of product ordered for three consecutive months for loan payback terms (in lbs.)	80,000
AVEKA Nutra Processing, LLC [Member] \| Note Receivable [Member]	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'
Maximum borrowing capacity	500,000
Loan advances	10,000
Interest rate on loan receivable (in hundredths)	5.50%
Operating cost drawdown for capital expenditures, maximum	5,000
Credit drawn down maximum per period	75,000
Drawdown period threshold	'30 days
Loan payback terms	'The loan is to be paid back to the Company in the form of discounts on production pricing commencing either two years after the first draw by ANP on the line of credit (other than the $10,000 the Company loaned ANP to assist it with the purchase of its Waukon, Iowa facility) or the first month after the Company has ordered 80,000 lbs. of product for three consecutive months, whichever shall occur first.
Line of credit advances	500,000
Interest accrued on the advance	50,650
Periodic collections of advances and accrued interest	5,000

ACCRUED_EXPENSES_Details

ACCRUED EXPENSES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
ACCRUED EXPENSES [Abstract]	'	'
Accrued payroll and taxes	$51,566	$32,021
Accrued settlements	102,000	110,000
Accrued expenses and other	40,578	31,513
Total accrued expenses	$194,144	$173,534

CONVERTIBLE_NOTES_PAYABLE_Deta

CONVERTIBLE NOTES PAYABLE (Details) (USD $)	12 Months Ended			3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Sep. 18, 2013	Mar. 31, 2012	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012
				Accredited Investor [Member]	Convertible Notes [Member]	2012 Convertible Notes [Member]	2012 Convertible Notes [Member]	2012 Convertible Notes [Member]	2012 Convertible Notes [Member]
				AccreditedInvestors				Minimum [Member]	Maximum [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'
Number of investors	'	'	'	3	'	'	'	'	'
Proceeds from Issuance of notes	$0	$200,000	'	'	'	$200,000	'	'	'
Term of debt	'	'	'	'	'	'24 months	'	'	'
Interest rate on debt (in hundredths)	8.00%	'	'	'	'	'	8.00%	'	'
Notes conversion ratio into common stock (in dollars per unit)	'	'	'	'	'	'	1	'	'
Aggregate shares issuable on conversion of debt (in shares)	'	'	'	'	'	'	200,000	'	'
Common stock par value (in dollars per share)	'	'	'	'	'	'	$0.00	'	'
Interest rate ,default (in hundredths)	'	'	'	'	'	'	18.00%	'	'
Exercise price (in dollars per share)	'	'	$1.50	'	'	'	$1.50	'	'
Term of warrants	'	'	'	'	'	'	'5 years	'	'
Discount on convertible debentures	'	'	'	'	'	'	40,508	'	'
Warrants issued (in shares)	'	'	'	'	'	'	100,000	'	'
Warrant grand date exercise price (in dollars per share)	'	'	'	'	'	'	'	$0.59	$0.70
Fair Value Assumptions, Expected Volatility Rate (in hundredths)	'	'	'	'	'	'	'	98.16%	103.66%
Fair Value Inputs, Discount Rate (in hundredths)	'	'	'	'	'	'	'	0.91%	0.88%
Debt discount, net of amortization	'	'	'	'	'	'	40,608	'	'
Principal converted into stock	'	'	'	'	'	'	200,000	'	'
Amortization of debt discount	$0	$78,819	'	'	$78,819	'	'	'	'

PREFERRED_STOCK_Details

PREFERRED STOCK (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Dec. 11, 2012

Aug. 15, 2012

Dec. 31, 2013

Dec. 31, 2012

Sep. 18, 2013

Sep. 07, 2012

Dec. 31, 2013

Dec. 31, 2012

Nov. 18, 2013

Sep. 30, 2013

Aug. 20, 2013

Mar. 31, 2013

Feb. 28, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 29, 2012

Dec. 07, 2012

Sep. 07, 2012

Aug. 15, 2012

Mar. 18, 2013

Dec. 31, 2012

Aug. 13, 2012

Dec. 31, 2012

Dec. 11, 2012

Aug. 15, 2012

Dec. 15, 2012

Series II Convertible Preferred Stock [Member]

Warrant [Member]

Series II [Member]

Series I and II [Member]

Brightline Ventures I, LLC [Member]

External directors [Member]

Accredited Investor [Member]

Series II Convertible Preferred Stock [Member]

Series I [Member]

Series II [Member]

Series I and II [Member]

Series I [Member]

Subsidiary, Sale of Stock [Line Items]

Value of convertible preferred stock converted into common stock

$3,326,697

Number of common shares issuable upon conversion (in shares)

11,582,983

2,859,375

Warrant exercise price (in dollars per share)

$1.50

$1.25

$1.50

The percentage that the 2,859,375 warrants are of the total (in hundredths)

50.00%

Gross amount reclassified to permanent equity

665,339

3,326,697

Carrying value reclassified to permanent equity on the date of the transaction

2,157,238

Debt discount, net of amortization

1,169,459

Value of accrued dividends on convertible preferred stock converted into common stock

533,000

Common stock issued for conversion of convertible preferred stock (in shares)

17,403

34,800

3,859,697

Preferred stock, shares outstanding (in shares)

665,339

Preferred stock converted

2,690,056

5,493,914

2,690,239

Dividends Payable

476,857

Stock issued for conversion of convertible notes

1,871,034

905,348

2,559,752

727,280

907,120

7,721,988

69,612

17,403

34,800

290,000

Number of shares outstanding preferred shares convert into common stock (in shares)

727,280

3,326,697

905,348

2,559,752

907,120

3,326,697

7,721,988

17,403

34,800

290,000

Net loss from conversion of stock

$728

LIQUIDATED_DAMAGES_Details

LIQUIDATED DAMAGES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
	Investor	Dec. 31, 2012
LIQUIDATED DAMAGES [Abstract]	'	'
Liquidation damages (in hundredths)	1.50%	'
Liquidation damages base period	'Each 30-day period or pro rata for any portion thereof following the Filing Deadline for which no registration statement was filed	'
Number of investors who have signed a release and waiver	74	'
Number of investors who have not signed a release and waiver	3	'
Accrued liquidated damages	$36,178	$36,178
Number of investors who signed a release and waiver during the period	2	'
Gain related to reduction of potential claims	$74,850	'

DERIVATIVE_LIABILITIES_Details

DERIVATIVE LIABILITIES (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Sep. 18, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Aug. 20, 2013

Nov. 18, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Common Stock Warrants [Member]

Embedded Conversion Features - Part of Note Discount [Member]

Derivative liabilities [Member]

Warrant [Member]

Common Stock [Member]

Exercise of Warrants [Member]

Conversion of 2008 and 2010 notes payable [Member]

Conversion of Series I Preferred Stock and accrued dividends [Member]

Conversion of Series II Preferred Stock and accrued dividends [Member]

Embedded Conversion Features - Part of Note Discount [Member]

DERIVATIVE LIABILITIES [Abstract]

Interest rate on convertible notes (in hundredths)

8.00%

Change attributable to conversion of the preferred stock

$2,761,688

$1,607,313

Change associated with the exercise of warrants

4,201,908

2,864,275

Derivatives, Fair Value [Line Items]

Derivative liabilities

95,049

8,025,381

95,049

6,626,255

1,399,126

Derivative Liability [Roll Forward]

Beginning Balance

8,025,381

11,031,432

95,049

6,626,255

1,399,126

Change in fair value of derivative liability

-966,736

1,514,156

Change in derivative liability - settlements and conversion

-6,963,596

-4,520,207

-2,489,552

-1,021,913

-48,619

-2,761,688

-3,449,675

Total

95,049

8,025,381

95,049

6,626,255

1,399,126

Stock issued for conversions (in shares)

5,893,887

689,087

1,658,979

5,493,912

3,859,697

Increase in additional paid in capital as a result of conversions

2,489,552

1,021,913

48,619

3,449,675

2,761,688

Share price (in dollars per share)

$0.56

$1.74

$0.75

Market capitalization

28,625,236

71,338,556

Projected volatility based on a historical value (in hundredths)

93.00%

182.00%

Probability of an event to default (in hundredths)

5.00%

Percentage in probability of an event to default per month (in hundredths)

0.10%

Warrant exercise price (in dollars per share)

$1.50

Exercise price of unexercised warrants (in dollars per share)

$1.25

Unexercised warrants description

'for every five warrants owned, each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25.

Base number of warrants considered for additional warrant (in shares)

Number of warrants that not exercised (in shares)

11,880,047

Warrants issued to purchase common stock (in shares)

234,286

2,376,009

1,400,000

Warrants issued (in shares)

2,316,597

Settlement to additional paid in capital for related derivative liability

1,712,356

Shares sold (in shares)

1,866,667

Warrants issued

$57,729

EQUITY_Details

EQUITY (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

0 Months Ended

Nov. 18, 2013

Jan. 22, 2013

Dec. 11, 2012

Aug. 15, 2012

Dec. 31, 2013

Dec. 31, 2012

Sep. 18, 2013

Nov. 18, 2013

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 22, 2013

Feb. 06, 2012

Dec. 31, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 03, 2013

Oct. 28, 2013

Aug. 20, 2013

Sep. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Nov. 18, 2013

Feb. 28, 2013

Dec. 31, 2012

Feb. 12, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jul. 02, 2012

Dec. 31, 2012

Mar. 31, 2013

Sep. 18, 2013

Aug. 20, 2013

Mar. 18, 2013

Common Stock [Member]

Common Stock Issued To Non Executive Directors [Member]

Common Stock Issued on Converted Notes [Member]

Restricted Shares of Common Stock [Member]

Warrant [Member]

Common Stock Payable [Member]

Investors [Member]

Former And Current Employee [Member]

Former Employee [Member]

Maxim [Member]

Brightline [Member]

Director

Warrant [Member]

Employee

Common Stock [Member]

Series II [Member]

Subsidiary, Sale of Stock [Line Items]

Shares issued for services (in shares)

114,944

238,800

550,000

220,000

150,000

Number of directors shares approved

Consulting agreement termination date

31-Jan-15

31-Jan-14

Common stock valued

$569,800

Stock issued for services

630,933

150,000

Shares issued for services (in shares)

28,736

59,700

Additional professional services costs

'$10,000 per month for the duration of this agreement.

Monthly professional services costs

10,000

Professional fees

200,002

160,000

Advisory services agreement amount

10,000,000

Number of additional shares to be issued for services under agreement (in shares)

350,000

Additional amount to be received minimum

10,000,000

Shares issued upon conversion of convertible notes (in shares)

17,403

34,800

212,056

150,979

1,508,000

3,859,697

Common stock, par value (in dollars per share)

$0.00

Principal amount of debt converted

200,000

120,000

1,300,000

Interest rate on convertible notes (in hundredths)

8.00%

Interest amount of debt converted

12,056

30,979

208,000

Warrants exercised for cash (in shares)

1,756,088

490,424

531,642

Warrants exercised for cash

2,489,846

304,225

2,195,110

304,225

294,736

Cashless exercise of warrants (in shares)

3,606,157

198,663

7,172,751

1,756,088

198,663

909,784

Warrant exercise price (in dollars per share)

$1.50

$1.25

Expense for modification of warrants previously issued for services

5,780,457

4,789,801

Company stock price on date of modification (in dollars per share)

$2.30

Volatility of stock price (in hundredths)

109.96%

Discount rate used (in hundredths)

0.06%

Number of warrants that not exercised (in shares)

11,880,047

Warrants issued to purchase common stock (in shares)

234,286

2,376,009

1,400,000

Warrant exercise description

'for every ten $1.50 warrants exercised, the holder received 4.5 shares of Common Stock (fractional shares were rounded up)

Base number of warrants consider for conversion of shares (in shares)

Number of shares to be issued for exercise of ten warrants (in shares)

'4.50

Exercise price of unexercised warrants (in dollars per share)

$1.25

Unexercised warrants description

'for every five warrants owned, each remaining holder of $1.50 warrants received one additional warrant with an exercise price of $1.25 per share.

Base number of warrants considered for additional warrant (in shares)

Exercised cashless stock options (in shares)

100,528

131,161

100,528

131,161

3,227,742

378,415

Warrants converted into common stock (in shares)

5,718,750

Common stock issued for conversion of warrants (in shares)

2,573,438

Loss on equity modification

-990,656

Warrants issued (in shares)

2,316,597

Settlement to additional paid in capital for related derivative liability

1,712,356

Common shares issued upon cashless exercise of warrants (in shares)

100,528

131,161

100,528

131,161

3,227,742

378,415

Number of former employees exercised stock options

Exercised stock options for cash (in shares)

14,600

91,400

Exercised stock options for cash

77,734

9,526

Cashless stock options exercised (in shares)

202,250

Shares sold (in shares)

1,866,667

468,571

376,000

Share price (in dollars per share)

$0.75

$1.05

$1.25

Proceeds from issuance of private placement

492,000

470,000

Proceeds from Issuance Initial Public Offering

1,210,165

Number of shares issued under settlement agreement (in shares)

875,000

Stock to be issued for settlement loss

1,881,250

Value of convertible preferred stock converted into common stock

3,326,697

Value of accrued dividends on convertible preferred stock converted into common stock

$533,000

Common stock issued for conversion of convertible preferred stock (in shares)

17,403

34,800

212,056

150,979

1,508,000

3,859,697

STOCK_OPTION_PLAN_AND_WARRANTS2

STOCK OPTION PLAN AND WARRANTS (Details) (USD $)	0 Months Ended	12 Months Ended
STOCK OPTION PLAN AND WARRANTS (Details) (USD $)	Aug. 20, 2013	Dec. 31, 2013	Dec. 31, 2012	Nov. 18, 2013	Oct. 21, 2013	Sep. 18, 2013
Class of Warrant or Right [Line Items]	'	'	'	'	'	'
Stock options exercised (in shares)	'	91,400	14,600	'	'	'
Exercised cashless stock options (in shares)	'	100,528	131,161	'	'	'
Warrants [Roll Forward]	'	'	'	'	'	'
Granted (in shares)	'	'	650,000	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Outstanding at beginning of period (in dollar per share)	'	'	'	'	'	$1.50
Outstanding, end of period (in dollar per share)	'	'	'	'	'	$1.50
Fair value of warrants	'	'	$273,641	'	'	'
Warrants issued to purchase common stock (in shares)	'	'	'	'	'	234,286
Common Stock [Member]	'	'	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'	'	'
Exercised cashless warrants (in shares)	'	3,606,157	198,663	'	'	'
Exercised cashless stock options (in shares)	'	100,528	131,161	'	'	'
Warrant [Member]	'	'	'	'	'	'
Warrants [Roll Forward]	'	'	'	'	'	'
Outstanding at beginning of period (in shares)	'	23,392,811	23,752,669	'	'	'
Granted (in shares)	'	4,010,295	650,000	'	'	'
Exercised (in shares)	'	-2,287,730	-490,424	'	'	'
Cashless Exercises (in shares)	'	-8,082,535	-335,541	'	'	'
Expired and Cancelled (in shares)	'	-344,576	-183,893	'	'	'
Outstanding, end of period (in shares)	'	16,688,265	23,392,811	'	'	'
Exercisable at end of period (in shares)	'	16,688,265	23,392,811	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Outstanding at beginning of period (in dollar per share)	'	$1.46	$1.55	'	'	'
Granted (in dollar per share)	'	$1.18	$0.83	'	'	'
Exercised (in dollar per share)	'	$1.28	$0.62	'	'	'
Cashless Exercises (in dollar per share)	'	$1.43	$0.91	'	'	'
Expired and cancelled (in dollar per share)	'	$0.88	$14.73	'	'	'
Outstanding, end of period (in dollar per share)	'	$1.44	$1.46	'	'	'
Exercisable at end of period (in dollar per share)	'	$1.44	$1.46	'	'	'
Warrants issued to purchase common stock (in shares)	2,376,009	'	'	1,400,000	30,000	234,286
Warrants issued (in shares)	2,316,597	'	'	'	'	'
Warrant exercise price (in dollars per share)	$1.50	'	'	$1	'	$1.50
Amortization expense related to warrants	'	172,000	'	'	'	'
Exercise price of unexercised warrants (in dollars per share)	$1.25	'	'	'	'	'
Base number of warrants considered for additional warrant (in shares)	5	'	'	'	'	'
Warrant [Member] \| Minimum [Member]	'	'	'	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Inception to date, weighted average issue price (in dollars per share)	'	$0.01	$0.01	'	'	'
Warrant [Member] \| Maximum [Member]	'	'	'	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Inception to date, weighted average issue price (in dollars per share)	'	$1.50	$1.50	'	'	'
Warrants for Investors and Services [Member]	'	'	'	'	'	'
Warrants [Roll Forward]	'	'	'	'	'	'
Granted (in shares)	'	'	550,000	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Fair value of warrants	'	'	233,133	'	'	'
Warrants Attached to Debt [Member]	'	'	'	'	'	'
Warrants [Roll Forward]	'	'	'	'	'	'
Granted (in shares)	'	'	100,000	'	'	'
Warrants weighted average exercise price [Roll Forward]	'	'	'	'	'	'
Fair value of warrants	'	'	$40,508	'	'	'

STOCK_OPTION_PLAN_AND_WARRANTS3

STOCK OPTION PLAN AND WARRANTS, STOCK OPTIONS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock option fair value assumptions [Abstract]	'	'
Stock based compensation expense	$2,318,355	$1,547,826
Stock Options [Member]	'	'
Number of shares [Roll Forward]	'	'
Outstanding at beginning of period (in shares)	7,728,877	5,645,202
Granted (in shares)	2,176,535	2,354,275
Exercised (in shares)	-293,650	-230,600
Expired and Cancelled (in shares)	-28,000	-40,000
Outstanding at end of period (in shares)	9,583,762	7,728,877
Exercisable at the end of the period (in shares)	9,536,262	7,582,022
Weighted average exercise price [Roll Forward]	'	'
Outstanding at the beginning of period (in dollars per share)	$1.01	$1.10
Granted (in dollars per share)	$1.67	$0.80
Exercised (in dollars per share)	$0.98	$1.09
Expired and Cancelled (in dollars per share)	$2.18	$0.86
Outstanding at end of period (in dollars per share)	$1.16	$1.01
Exercisable at end of the period (in dollars per share)	$1.17	$1.03
Additional Disclosures [Abstract]	'	'
Aggregate intrinsic value	0	'
Weighted average remaining contractual term	'3 years 3 months 18 days	'
Stock option fair value assumptions [Abstract]	'	'
Weighted average fair value per option granted (in dollars per share)	$1.04	$0.38
Risk free interest rate minimum (in hundredths)	0.65%	0.34%
Risk free interest rate maximum (in hundredths)	0.81%	0.42%
Expected dividend yield (in hundredths)	0.00%	0.00%
Expected lives	'2 years 8 months 10 days	'2 years 8 months 10 days
Expected volatility rate minimum (in hundredths)	99.79%	97.72%
Expected volatility rate maximum (in hundredths)	108.00%	103.00%
Expiration from date of grant	'P5Y	'P5Y
Shares available for issuance under the Plan (in shares)	8,416,238	10,271,123
Unrecognized stock based compensation to be recognized	22,103	77,595
Stock Options [Member] \| Employees [Member]	'	'
Number of shares [Roll Forward]	'	'
Granted (in shares)	2,176,535	2,324,275
Stock option fair value assumptions [Abstract]	'	'
Stock based compensation expense	$2,318,355	$96,599
Percentage of options that vested at grant date (in hundredths)	'	25.00%
Award vesting percentage on 90 days subsequent to the grant date (in hundredths)	'	25.00%
Award vesting percentage on 180 days subsequent to the grant date (in hundredths)	'	25.00%
Award vesting percentage on 270 days subsequent to the grant date (in hundredths)	'	25.00%

STOCK_OPTION_PLAN_AND_WARRANTS4

STOCK OPTION PLAN AND WARRANTS, PRICE RANGE (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Options outstanding (in shares)	9,583,762	5,645,202
Weighted average remaining contractual life	'3 years 3 months 18 days	'4 years
Weighted average exercise price (in dollars per share)	$1.17	$1.13
Options exercisable (in shares)	9,536,262	5,317,003
$0.01 - $1.50 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Range of exercise prices lower (in dollars per share)	$0.01	$0.01
Range of exercise prices upper (in dollars per share)	$1.50	$1.50
Options outstanding (in shares)	7,090,227	5,435,202
Weighted average remaining contractual life	'2 years 9 months 18 days	'3 years 10 months 24 days
Weighted average exercise price (in dollars per share)	$0.97	$1.18
Options exercisable (in shares)	7,090,227	5,107,003
$1.51 - $3.00 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Range of exercise prices lower (in dollars per share)	$1.51	$1.51
Range of exercise prices upper (in dollars per share)	$3	$3
Options outstanding (in shares)	2,368,535	210,000
Weighted average remaining contractual life	'4 years 6 months	'2 years
Weighted average exercise price (in dollars per share)	$1.67	$1.49
Options exercisable (in shares)	2,368,535	210,000
$3.00 - $5.00 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Range of exercise prices lower (in dollars per share)	$3.01	'
Range of exercise prices upper (in dollars per share)	$5	'
Options outstanding (in shares)	125,000	'
Weighted average remaining contractual life	'4 years 7 months 6 days	'
Weighted average exercise price (in dollars per share)	$3.11	'
Options exercisable (in shares)	125,000	'

SETTLEMENT_LOSSES_Details

SETTLEMENT LOSSES (Details) (USD $)

3 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Feb. 12, 2013

Dec. 31, 2012

Jul. 07, 2007

Dec. 31, 2011

Mar. 06, 2012

Mar. 31, 2012

Dec. 31, 2011

Common Stock Payable [Member]

Violation of the Consumer Fraud Act [Member]

Breach of Contract and Tortuous Interference with Business Relationship [Member]

Mechanics lien on Property Leased [Member]

Minimum [Member]

Loss Contingency, Settlement [Abstract]

Damages sought in case

$200,000

$185,000

$95,000

Payment to the plaintiff

62,500

Settlement of lien

62,500

Amount accrued

62,500

Settlement loss (gain)

10,000

Payment for settlements

10,000

13,968

Reserve allocated for litigation settlement

102,000

Number of shares issued under settlement agreement (in shares)

875,000

Stock to be issued for settlement loss

$1,881,250

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
INCOME TAXES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
INCOME TAXES [Abstract]	'	'
Cumulative net loss carryforward	$96,624,455	$91,147,205
Statutory tax rate (in hundredths)	34.00%	34.00%
Components of net deferred tax asset [Abstract]	'	'
Net operating loss	32,852,315	30,990,050
Less: valuation allowance	-32,852,315	-30,990,050
Net deferred tax asset	$0	$0

MAJOR_CUSTOMERS_AND_CONCENTRAT1

MAJOR CUSTOMERS AND CONCENTRATIONS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
	Customer	Customer
Concentration Risk [Line Items]	'	'
Deposits that exceeded the federally insured limits	193,472	394,804
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member]	'	'
Concentration Risk [Line Items]	'	'
Number of customers above risk benchmark	3	3
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk (in hundredths)	36.00%	36.00%
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member] \| Customer Two [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk (in hundredths)	24.00%	24.00%
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member] \| Customer Three [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk (in hundredths)	5.00%	9.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member]	'	'
Concentration Risk [Line Items]	'	'
Number of customers above risk benchmark	2	2
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk (in hundredths)	61.00%	77.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer Two [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk (in hundredths)	11.00%	9.00%

COMMITMENTS_Details

COMMITMENTS (Details) (USD $)	12 Months Ended
COMMITMENTS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Future minimum annual rental payments and sub-lease income [Abstract]	'	'
2014	$256,332	'
2015	85,444	'
2016	0	'
2017	0	'
2018	0	'
Total	341,776	'
Total rent expense	280,696	324,397
Combined Production and Office Facility [Member]	'	'
Operating Leased Assets [Line Items]	'	'
Area of leased property (in sq. feet)	44,000	'
Required monthly rental payments	$21,361	'

LITIGATION_CONTINGENT_LIABILIT1

LITIGATION/ CONTINGENT LIABILITY (Details) (USD $)	12 Months Ended			0 Months Ended	1 Months Ended	12 Months Ended	0 Months Ended	3 Months Ended	1 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jul. 07, 2007	Jul. 07, 2007	Dec. 31, 2011	Dec. 31, 2011	Mar. 06, 2012	Mar. 31, 2012	Dec. 31, 2011	Dec. 31, 2011
			Violation of the Consumer Fraud Act [Member]	Violation of the Consumer Fraud Act [Member]	Breach of Contract and Tortuous Interference with Business Relationship [Member]	Breach of Contract and Tortuous Interference with Business Relationship [Member]	Mechanics lien on Property Leased [Member]	Mechanics lien on Property Leased [Member]	Mechanics lien on Property Leased [Member]	Mechanics lien on Property Leased [Member]
				Minimum [Member]	Minimum [Member]	Minimum [Member]			Minimum [Member]	Minimum [Member]
Loss Contingencies [Line Items]	'	'	'	'	'	'	'	'	'	'
Damages sought in case	'	'	'	$200,000	$185,000	$185,000	'	'	$95,000	$95,000
Reserve allocated for litigation settlement	'	'	102,000	'	'	'	'	'	'	'
Settlement of lien	'	'	'	'	'	'	62,500	62,500	'	'
Cash settlement	$10,000	$13,968	'	'	'	'	'	'	'	'

GUARANTEES_Details

GUARANTEES (Details)	12 Months Ended
GUARANTEES (Details)	Dec. 31, 2013
GUARANTEES [Abstract]	'
Standard product warranty description	'In general, the Company offers a one-year warranty for most of the products it sold.
Standard product warranty period	'1 year

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

Jan. 22, 2013

Dec. 11, 2012

Aug. 15, 2012

Dec. 31, 2013

Dec. 31, 2012

Sep. 18, 2013

Feb. 06, 2012

Mar. 06, 2013

Feb. 27, 2013

Mar. 31, 2013

Aug. 31, 2013

Mar. 31, 2013

Director

Non-Executive Directors [Member]

Morris Garfinkle [Member]

Mark Hershorn, Edward Smith and Brian Israel [Member]

Director

Factor

Related Party Transaction [Line Items]

Stock issued for directors fees (in shares)

114,944

238,800

Number of non executive directors

Shares issued for services per director (in shares)

28,736

59,700

Stock issued for directors fees

$200,002

$160,000

Amount of converted stock

17,403

34,800

69,612

Common stock issued for conversion of convertible preferred stock (in shares)

17,403

34,800

Recorded loss from aggregate conversion

728

Warrant exercise price (in dollars per share)

$1.50

Exercise price of unexercised warrants (in dollars per share)

$1.25

Warrants exercised for cash (in shares)

200,000

127,695

Common stock issued in conversion of warrants (in shares)

26,571

200,000

58,395

Compensation expense related to fair value of warrant modifications

$45,596

$24,281

Number of Shares Issued per 10 Warrants

'4.50

Conversion factor per warrant

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	0 Months Ended	12 Months Ended		0 Months Ended				1 Months Ended
	Jan. 22, 2013	Dec. 31, 2013	Dec. 31, 2012	Feb. 11, 2014	Mar. 24, 2014	Mar. 28, 2014	Jan. 02, 2014	Jan. 31, 2014
	Director			Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
				Edward Smith, Director and Shareholder [Member]	Fordham Capital Partners [Member]	AVEKA Nutra Processing, LLC [Member]	Non-Executive Directors [Member]	Non-Executive Directors [Member]
							Director
Subsequent Event [Line Items]	'	'	'	'	'	'	'	'
Stock issued for directors fees (in shares)	114,944	'	'	'	'	'	285,716	'
Number of non executive directors	4	'	'	'	'	'	4	'
Shares issued for services (in shares)	28,736	'	'	'	'	'	'	71,429
Stock issued for directors fees	$200,002	$200,002	$160,000	'	'	'	$160,001	'
Note payable to related parties	'	'	'	200,000	500,000	'	'	'
Period of maturity	'	'	'	'2 years	'	'	'	'
Maturity date	'	'	'	11-Feb-16	'	'	'	'
Interest rate on convertible senior secured notes (in hundredths)	'	8.00%	'	12.50%	20.00%	'	'	'
Monthly principal payments for note payable	'	'	'	'	10,417	'	'	'
Guaranteed interest period in case of prepayment of note payable	'	'	'	'	'6 months	'	'	'
Interest rate on note payable in event of default (in hundredths)	'	'	'	'	25.00%	'	'	'
Periodic collections of advances and accrued interest	'	'	'	'	'	$5,000	'	'